Medicare Code Edits · FY 2026 MCE v43.0

Unacceptable Principal Diagnosis ICD-10-CM

The unacceptable principal diagnosis edit is a check in Medicare’s claim-validation software, the Medicare Code Editor (MCE). It covers the 2,657 ICD-10-CM diagnosis codes listed below. These codes describe circumstances that influence health status without representing a current illness, so the MCE rejects any inpatient claim that lists one as the principal diagnosis. Reported as secondary diagnoses they are fine.

✓ Built from the official CMS MCE v43.0 datasetEffective Oct 1, 2025 – Sep 30, 2026
2,657
ICD-10-CM Codes
150
Code Categories
Never
As Principal Diagnosis
ICD-10-CM

Diagnosis Codes in This Edit 2,657 codes · 150 categories

2,657 of 2,657 shown
B95 Streptococcus, Staphylococcus, and Enterococcus as the cause of diseases classified elsewhere10 codes
  • B95.0 Streptococcus, group A, as the cause of diseases classified elsewhere
  • B95.1 Streptococcus, group B, as the cause of diseases classified elsewhere
  • B95.2 Enterococcus as the cause of diseases classified elsewhere
  • B95.3 Streptococcus pneumoniae as the cause of diseases classified elsewhere
  • B95.4 Other streptococcus as the cause of diseases classified elsewhere
  • B95.5 Unspecified streptococcus as the cause of diseases classified elsewhere
  • B95.61 Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere
  • B95.62 Methicillin resistant Staphylococcus aureus infection as the cause of diseases classified elsewhere
  • B95.7 Other staphylococcus as the cause of diseases classified elsewhere
  • B95.8 Unspecified staphylococcus as the cause of diseases classified elsewhere
B96 Other bacterial agents as the cause of diseases classified elsewhere16 codes
  • B96.0 Mycoplasma pneumoniae [M. pneumoniae] as the cause of diseases classified elsewhere
  • B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere
  • B96.20 Unspecified Escherichia coli [E. coli] as the cause of diseases classified elsewhere
  • B96.21 Shiga toxin-producing Escherichia coli [E. coli] [STEC] O157 as the cause of diseases classified elsewhere
  • B96.22 Other specified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere
  • B96.23 Unspecified Shiga toxin-producing Escherichia coli [E. coli] [STEC] as the cause of diseases classified elsewhere
  • B96.29 Other Escherichia coli [E. coli] as the cause of diseases classified elsewhere
  • B96.3 Hemophilus influenzae [H. influenzae] as the cause of diseases classified elsewhere
  • B96.4 Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere
  • B96.5 Pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere
  • B96.6 Bacteroides fragilis [B. fragilis] as the cause of diseases classified elsewhere
  • B96.7 Clostridium perfringens [C. perfringens] as the cause of diseases classified elsewhere
  • B96.81 Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
  • B96.82 Vibrio vulnificus as the cause of diseases classified elsewhere
  • B96.83 Acinetobacter baumannii as the cause of diseases classified elsewhere
  • B96.89 Other specified bacterial agents as the cause of diseases classified elsewhere
B97 Viral agents as the cause of diseases classified elsewhere20 codes
  • B97.0 Adenovirus as the cause of diseases classified elsewhere
  • B97.10 Unspecified enterovirus as the cause of diseases classified elsewhere
  • B97.11 Coxsackievirus as the cause of diseases classified elsewhere
  • B97.12 Echovirus as the cause of diseases classified elsewhere
  • B97.19 Other enterovirus as the cause of diseases classified elsewhere
  • B97.21 SARS-associated coronavirus as the cause of diseases classified elsewhere
  • B97.29 Other coronavirus as the cause of diseases classified elsewhere
  • B97.30 Unspecified retrovirus as the cause of diseases classified elsewhere
  • B97.31 Lentivirus as the cause of diseases classified elsewhere
  • B97.32 Oncovirus as the cause of diseases classified elsewhere
  • B97.33 Human T-cell lymphotrophic virus, type I [HTLV-I] as the cause of diseases classified elsewhere
  • B97.34 Human T-cell lymphotrophic virus, type II [HTLV-II] as the cause of diseases classified elsewhere
  • B97.35 Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere
  • B97.39 Other retrovirus as the cause of diseases classified elsewhere
  • B97.4 Respiratory syncytial virus as the cause of diseases classified elsewhere
  • B97.5 Reovirus as the cause of diseases classified elsewhere
  • B97.6 Parvovirus as the cause of diseases classified elsewhere
  • B97.7 Papillomavirus as the cause of diseases classified elsewhere
  • B97.81 Human metapneumovirus as the cause of diseases classified elsewhere
  • B97.89 Other viral agents as the cause of diseases classified elsewhere
C80 Malignant neoplasm without specification of site1 code
  • C80.2 Malignant neoplasm associated with transplanted organ
D47 Other neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue1 code
  • D47.Z1 Post-transplant lymphoproliferative disorder (PTLD)
D89 Other disorders involving the immune mechanism, not elsewhere classified10 codes
  • D89.810 Acute graft-versus-host disease
  • D89.811 Chronic graft-versus-host disease
  • D89.812 Acute on chronic graft-versus-host disease
  • D89.813 Graft-versus-host disease, unspecified
  • D89.831 Cytokine release syndrome, grade 1
  • D89.832 Cytokine release syndrome, grade 2
  • D89.833 Cytokine release syndrome, grade 3
  • D89.834 Cytokine release syndrome, grade 4
  • D89.835 Cytokine release syndrome, grade 5
  • D89.839 Cytokine release syndrome, grade unspecified
E88 Other and unspecified metabolic disorders1 code
  • E88.A Wasting disease (syndrome) due to underlying condition
F05 Delirium due to known physiological condition1 code
  • F05 Delirium due to known physiological condition
F06 Other mental disorders due to known physiological condition2 codes
  • F06.70 Mild neurocognitive disorder due to known physiological condition without behavioral disturbance
  • F06.71 Mild neurocognitive disorder due to known physiological condition with behavioral disturbance
F07 Personality and behavioral disorders due to known physiological condition3 codes
  • F07.0 Personality change due to known physiological condition
  • F07.81 Postconcussional syndrome
  • F07.89 Other personality and behavioral disorders due to known physiological condition
F17 Nicotine dependence8 codes
  • F17.200 Nicotine dependence, unspecified, uncomplicated
  • F17.201 Nicotine dependence, unspecified, in remission
  • F17.210 Nicotine dependence, cigarettes, uncomplicated
  • F17.211 Nicotine dependence, cigarettes, in remission
  • F17.220 Nicotine dependence, chewing tobacco, uncomplicated
  • F17.221 Nicotine dependence, chewing tobacco, in remission
  • F17.290 Nicotine dependence, other tobacco product, uncomplicated
  • F17.291 Nicotine dependence, other tobacco product, in remission
F52 Sexual dysfunction not due to a substance or known physiological condition1 code
  • F52.9 Unspecified sexual dysfunction not due to a substance or known physiological condition
F81 Specific developmental disorders of scholastic skills1 code
  • F81.9 Developmental disorder of scholastic skills, unspecified
G73 Disorders of myoneural junction and muscle in diseases classified elsewhere1 code
  • G73.1 Lambert-Eaton syndrome in neoplastic disease
G92 Toxic encephalopathy6 codes
  • G92.00 Immune effector cell-associated neurotoxicity syndrome, grade unspecified
  • G92.01 Immune effector cell-associated neurotoxicity syndrome, grade 1
  • G92.02 Immune effector cell-associated neurotoxicity syndrome, grade 2
  • G92.03 Immune effector cell-associated neurotoxicity syndrome, grade 3
  • G92.04 Immune effector cell-associated neurotoxicity syndrome, grade 4
  • G92.05 Immune effector cell-associated neurotoxicity syndrome, grade 5
H16 Keratitis1 code
  • H16.9 Unspecified keratitis
H36 Retinal disorders in diseases classified elsewhere8 codes
  • H36.811 Nonproliferative sickle-cell retinopathy, right eye
  • H36.812 Nonproliferative sickle-cell retinopathy, left eye
  • H36.813 Nonproliferative sickle-cell retinopathy, bilateral
  • H36.819 Nonproliferative sickle-cell retinopathy, unspecified eye
  • H36.821 Proliferative sickle-cell retinopathy, right eye
  • H36.822 Proliferative sickle-cell retinopathy, left eye
  • H36.823 Proliferative sickle-cell retinopathy, bilateral
  • H36.829 Proliferative sickle-cell retinopathy, unspecified eye
H40 Glaucoma48 codes
  • H40.1210 Low-tension glaucoma, right eye, stage unspecified
  • H40.1211 Low-tension glaucoma, right eye, mild stage
  • H40.1212 Low-tension glaucoma, right eye, moderate stage
  • H40.1213 Low-tension glaucoma, right eye, severe stage
  • H40.1214 Low-tension glaucoma, right eye, indeterminate stage
  • H40.1220 Low-tension glaucoma, left eye, stage unspecified
  • H40.1221 Low-tension glaucoma, left eye, mild stage
  • H40.1222 Low-tension glaucoma, left eye, moderate stage
  • H40.1223 Low-tension glaucoma, left eye, severe stage
  • H40.1224 Low-tension glaucoma, left eye, indeterminate stage
  • H40.1230 Low-tension glaucoma, bilateral, stage unspecified
  • H40.1231 Low-tension glaucoma, bilateral, mild stage
  • H40.1232 Low-tension glaucoma, bilateral, moderate stage
  • H40.1233 Low-tension glaucoma, bilateral, severe stage
  • H40.1234 Low-tension glaucoma, bilateral, indeterminate stage
  • H40.1290 Low-tension glaucoma, unspecified eye, stage unspecified
  • H40.1291 Low-tension glaucoma, unspecified eye, mild stage
  • H40.1292 Low-tension glaucoma, unspecified eye, moderate stage
  • H40.1293 Low-tension glaucoma, unspecified eye, severe stage
  • H40.1294 Low-tension glaucoma, unspecified eye, indeterminate stage
  • H40.1310 Pigmentary glaucoma, right eye, stage unspecified
  • H40.1311 Pigmentary glaucoma, right eye, mild stage
  • H40.1312 Pigmentary glaucoma, right eye, moderate stage
  • H40.1313 Pigmentary glaucoma, right eye, severe stage
  • H40.1314 Pigmentary glaucoma, right eye, indeterminate stage
  • H40.1320 Pigmentary glaucoma, left eye, stage unspecified
  • H40.1321 Pigmentary glaucoma, left eye, mild stage
  • H40.1322 Pigmentary glaucoma, left eye, moderate stage
  • H40.1323 Pigmentary glaucoma, left eye, severe stage
  • H40.1324 Pigmentary glaucoma, left eye, indeterminate stage
  • H40.1330 Pigmentary glaucoma, bilateral, stage unspecified
  • H40.1331 Pigmentary glaucoma, bilateral, mild stage
  • H40.1332 Pigmentary glaucoma, bilateral, moderate stage
  • H40.1333 Pigmentary glaucoma, bilateral, severe stage
  • H40.1334 Pigmentary glaucoma, bilateral, indeterminate stage
  • H40.1390 Pigmentary glaucoma, unspecified eye, stage unspecified
  • H40.1391 Pigmentary glaucoma, unspecified eye, mild stage
  • H40.1392 Pigmentary glaucoma, unspecified eye, moderate stage
  • H40.1393 Pigmentary glaucoma, unspecified eye, severe stage
  • H40.1394 Pigmentary glaucoma, unspecified eye, indeterminate stage
  • H40.151 Residual stage of open-angle glaucoma, right eye
  • H40.152 Residual stage of open-angle glaucoma, left eye
  • H40.153 Residual stage of open-angle glaucoma, bilateral
  • H40.159 Residual stage of open-angle glaucoma, unspecified eye
  • H40.841 Neovascular secondary angle closure glaucoma, right eye
  • H40.842 Neovascular secondary angle closure glaucoma, left eye
  • H40.843 Neovascular secondary angle closure glaucoma, bilateral
  • H40.849 Neovascular secondary angle closure glaucoma, unspecified eye
H54 Blindness and low vision1 code
  • H54.7 Unspecified visual loss
H57 Other disorders of eye and adnexa1 code
  • H57.9 Unspecified disorder of eye and adnexa
H93 Other disorders of ear, not elsewhere classified4 codes
  • H93.90 Unspecified disorder of ear, unspecified ear
  • H93.91 Unspecified disorder of right ear
  • H93.92 Unspecified disorder of left ear
  • H93.93 Unspecified disorder of ear, bilateral
I25 Chronic ischemic heart disease3 codes
  • I25.82 Chronic total occlusion of coronary artery
  • I25.83 Coronary atherosclerosis due to lipid rich plaque
  • I25.84 Coronary atherosclerosis due to calcified coronary lesion
I26 Pulmonary embolism4 codes
  • I26.01 Septic pulmonary embolism with acute cor pulmonale
  • I26.03 Cement embolism of pulmonary artery with acute cor pulmonale
  • I26.90 Septic pulmonary embolism without acute cor pulmonale
  • I26.95 Cement embolism of pulmonary artery without acute cor pulmonale
I31 Other diseases of pericardium1 code
I46 Cardiac arrest2 codes
  • I46.2 Cardiac arrest due to underlying cardiac condition
  • I46.8 Cardiac arrest due to other underlying condition
I70 Atherosclerosis1 code
  • I70.92 Chronic total occlusion of artery of the extremities
I76 Septic arterial embolism1 code
  • I76 Septic arterial embolism
J12 Viral pneumonia, not elsewhere classified1 code
  • J12.82 Pneumonia due to coronavirus disease 2019
J34 Other and unspecified disorders of nose and nasal sinuses7 codes
  • J34.8200 Internal nasal valve collapse, unspecified
  • J34.8201 Internal nasal valve collapse, static
  • J34.8202 Internal nasal valve collapse, dynamic
  • J34.8210 External nasal valve collapse, unspecified
  • J34.8211 External nasal valve collapse, static
  • J34.8212 External nasal valve collapse, dynamic
  • J34.829 Nasal valve collapse, unspecified
J93 Pneumothorax and air leak1 code
  • J93.12 Secondary spontaneous pneumothorax
K74 Fibrosis and cirrhosis of liver3 codes
  • K74.00 Hepatic fibrosis, unspecified
  • K74.01 Hepatic fibrosis, early fibrosis
  • K74.02 Hepatic fibrosis, advanced fibrosis
K76 Other diseases of liver1 code
  • K76.81 Hepatopulmonary syndrome
L49 Exfoliation due to erythematous conditions according to extent of body surface involved10 codes
  • L49.0 Exfoliation due to erythematous condition involving less than 10 percent of body surface
  • L49.1 Exfoliation due to erythematous condition involving 10-19 percent of body surface
  • L49.2 Exfoliation due to erythematous condition involving 20-29 percent of body surface
  • L49.3 Exfoliation due to erythematous condition involving 30-39 percent of body surface
  • L49.4 Exfoliation due to erythematous condition involving 40-49 percent of body surface
  • L49.5 Exfoliation due to erythematous condition involving 50-59 percent of body surface
  • L49.6 Exfoliation due to erythematous condition involving 60-69 percent of body surface
  • L49.7 Exfoliation due to erythematous condition involving 70-79 percent of body surface
  • L49.8 Exfoliation due to erythematous condition involving 80-89 percent of body surface
  • L49.9 Exfoliation due to erythematous condition involving 90 or more percent of body surface
M40 Kyphosis and lordosis5 codes
  • M40.10 Other secondary kyphosis, site unspecified
  • M40.12 Other secondary kyphosis, cervical region
  • M40.13 Other secondary kyphosis, cervicothoracic region
  • M40.14 Other secondary kyphosis, thoracic region
  • M40.15 Other secondary kyphosis, thoracolumbar region
M41 Scoliosis7 codes
  • M41.50 Other secondary scoliosis, site unspecified
  • M41.52 Other secondary scoliosis, cervical region
  • M41.53 Other secondary scoliosis, cervicothoracic region
  • M41.54 Other secondary scoliosis, thoracic region
  • M41.55 Other secondary scoliosis, thoracolumbar region
  • M41.56 Other secondary scoliosis, lumbar region
  • M41.57 Other secondary scoliosis, lumbosacral region
N64 Other disorders of breast1 code
  • N64.1 Fat necrosis of breast
O09 Supervision of high risk pregnancy64 codes
  • O09.00 Supervision of pregnancy with history of infertility, unspecified trimester
  • O09.01 Supervision of pregnancy with history of infertility, first trimester
  • O09.02 Supervision of pregnancy with history of infertility, second trimester
  • O09.03 Supervision of pregnancy with history of infertility, third trimester
  • O09.10 Supervision of pregnancy with history of ectopic pregnancy, unspecified trimester
  • O09.11 Supervision of pregnancy with history of ectopic pregnancy, first trimester
  • O09.12 Supervision of pregnancy with history of ectopic pregnancy, second trimester
  • O09.13 Supervision of pregnancy with history of ectopic pregnancy, third trimester
  • O09.211 Supervision of pregnancy with history of pre-term labor, first trimester
  • O09.212 Supervision of pregnancy with history of pre-term labor, second trimester
  • O09.213 Supervision of pregnancy with history of pre-term labor, third trimester
  • O09.219 Supervision of pregnancy with history of pre-term labor, unspecified trimester
  • O09.291 Supervision of pregnancy with other poor reproductive or obstetric history, first trimester
  • O09.292 Supervision of pregnancy with other poor reproductive or obstetric history, second trimester
  • O09.293 Supervision of pregnancy with other poor reproductive or obstetric history, third trimester
  • O09.299 Supervision of pregnancy with other poor reproductive or obstetric history, unspecified trimester
  • O09.30 Supervision of pregnancy with insufficient antenatal care, unspecified trimester
  • O09.31 Supervision of pregnancy with insufficient antenatal care, first trimester
  • O09.32 Supervision of pregnancy with insufficient antenatal care, second trimester
  • O09.33 Supervision of pregnancy with insufficient antenatal care, third trimester
  • O09.40 Supervision of pregnancy with grand multiparity, unspecified trimester
  • O09.41 Supervision of pregnancy with grand multiparity, first trimester
  • O09.42 Supervision of pregnancy with grand multiparity, second trimester
  • O09.43 Supervision of pregnancy with grand multiparity, third trimester
  • O09.511 Supervision of elderly primigravida, first trimester
  • O09.512 Supervision of elderly primigravida, second trimester
  • O09.513 Supervision of elderly primigravida, third trimester
  • O09.519 Supervision of elderly primigravida, unspecified trimester
  • O09.521 Supervision of elderly multigravida, first trimester
  • O09.522 Supervision of elderly multigravida, second trimester
  • O09.523 Supervision of elderly multigravida, third trimester
  • O09.529 Supervision of elderly multigravida, unspecified trimester
  • O09.611 Supervision of young primigravida, first trimester
  • O09.612 Supervision of young primigravida, second trimester
  • O09.613 Supervision of young primigravida, third trimester
  • O09.619 Supervision of young primigravida, unspecified trimester
  • O09.621 Supervision of young multigravida, first trimester
  • O09.622 Supervision of young multigravida, second trimester
  • O09.623 Supervision of young multigravida, third trimester
  • O09.629 Supervision of young multigravida, unspecified trimester
  • O09.70 Supervision of high risk pregnancy due to social problems, unspecified trimester
  • O09.71 Supervision of high risk pregnancy due to social problems, first trimester
  • O09.72 Supervision of high risk pregnancy due to social problems, second trimester
  • O09.73 Supervision of high risk pregnancy due to social problems, third trimester
  • O09.811 Supervision of pregnancy resulting from assisted reproductive technology, first trimester
  • O09.812 Supervision of pregnancy resulting from assisted reproductive technology, second trimester
  • O09.813 Supervision of pregnancy resulting from assisted reproductive technology, third trimester
  • O09.819 Supervision of pregnancy resulting from assisted reproductive technology, unspecified trimester
  • O09.821 Supervision of pregnancy with history of in utero procedure during previous pregnancy, first trimester
  • O09.822 Supervision of pregnancy with history of in utero procedure during previous pregnancy, second trimester
  • O09.823 Supervision of pregnancy with history of in utero procedure during previous pregnancy, third trimester
  • O09.829 Supervision of pregnancy with history of in utero procedure during previous pregnancy, unspecified trimester
  • O09.891 Supervision of other high risk pregnancies, first trimester
  • O09.892 Supervision of other high risk pregnancies, second trimester
  • O09.893 Supervision of other high risk pregnancies, third trimester
  • O09.899 Supervision of other high risk pregnancies, unspecified trimester
  • O09.90 Supervision of high risk pregnancy, unspecified, unspecified trimester
  • O09.91 Supervision of high risk pregnancy, unspecified, first trimester
  • O09.92 Supervision of high risk pregnancy, unspecified, second trimester
  • O09.93 Supervision of high risk pregnancy, unspecified, third trimester
  • O09.A0 Supervision of pregnancy with history of molar pregnancy, unspecified trimester
  • O09.A1 Supervision of pregnancy with history of molar pregnancy, first trimester
  • O09.A2 Supervision of pregnancy with history of molar pregnancy, second trimester
  • O09.A3 Supervision of pregnancy with history of molar pregnancy, third trimester
O36 Maternal care for other fetal problems7 codes
  • O36.80X0 Pregnancy with inconclusive fetal viability, not applicable or unspecified
  • O36.80X1 Pregnancy with inconclusive fetal viability, fetus 1
  • O36.80X2 Pregnancy with inconclusive fetal viability, fetus 2
  • O36.80X3 Pregnancy with inconclusive fetal viability, fetus 3
  • O36.80X4 Pregnancy with inconclusive fetal viability, fetus 4
  • O36.80X5 Pregnancy with inconclusive fetal viability, fetus 5
  • O36.80X9 Pregnancy with inconclusive fetal viability, other fetus
O94 Sequelae of complication of pregnancy, childbirth, and the puerperium1 code
  • O94 Sequelae of complication of pregnancy, childbirth, and the puerperium
O99 Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium2 codes
  • O99.820 Streptococcus B carrier state complicating pregnancy
  • O99.825 Streptococcus B carrier state complicating the puerperium
R05 Cough1 code
R18 Ascites1 code
R29 Other symptoms and signs involving the nervous and musculoskeletal systems43 codes
R40 Somnolence, stupor and coma96 codes
  • R40.2110 Coma scale, eyes open, never, unspecified time
  • R40.2111 Coma scale, eyes open, never, in the field [EMT or ambulance]
  • R40.2112 Coma scale, eyes open, never, at arrival to emergency department
  • R40.2113 Coma scale, eyes open, never, at hospital admission
  • R40.2114 Coma scale, eyes open, never, 24 hours or more after hospital admission
  • R40.2120 Coma scale, eyes open, to pain, unspecified time
  • R40.2121 Coma scale, eyes open, to pain, in the field [EMT or ambulance]
  • R40.2122 Coma scale, eyes open, to pain, at arrival to emergency department
  • R40.2123 Coma scale, eyes open, to pain, at hospital admission
  • R40.2124 Coma scale, eyes open, to pain, 24 hours or more after hospital admission
  • R40.2130 Coma scale, eyes open, to sound, unspecified time
  • R40.2131 Coma scale, eyes open, to sound, in the field [EMT or ambulance]
  • R40.2132 Coma scale, eyes open, to sound, at arrival to emergency department
  • R40.2133 Coma scale, eyes open, to sound, at hospital admission
  • R40.2134 Coma scale, eyes open, to sound, 24 hours or more after hospital admission
  • R40.2140 Coma scale, eyes open, spontaneous, unspecified time
  • R40.2141 Coma scale, eyes open, spontaneous, in the field [EMT or ambulance]
  • R40.2142 Coma scale, eyes open, spontaneous, at arrival to emergency department
  • R40.2143 Coma scale, eyes open, spontaneous, at hospital admission
  • R40.2144 Coma scale, eyes open, spontaneous, 24 hours or more after hospital admission
  • R40.2210 Coma scale, best verbal response, none, unspecified time
  • R40.2211 Coma scale, best verbal response, none, in the field [EMT or ambulance]
  • R40.2212 Coma scale, best verbal response, none, at arrival to emergency department
  • R40.2213 Coma scale, best verbal response, none, at hospital admission
  • R40.2214 Coma scale, best verbal response, none, 24 hours or more after hospital admission
  • R40.2220 Coma scale, best verbal response, incomprehensible words, unspecified time
  • R40.2221 Coma scale, best verbal response, incomprehensible words, in the field [EMT or ambulance]
  • R40.2222 Coma scale, best verbal response, incomprehensible words, at arrival to emergency department
  • R40.2223 Coma scale, best verbal response, incomprehensible words, at hospital admission
  • R40.2224 Coma scale, best verbal response, incomprehensible words, 24 hours or more after hospital admission
  • R40.2230 Coma scale, best verbal response, inappropriate words, unspecified time
  • R40.2231 Coma scale, best verbal response, inappropriate words, in the field [EMT or ambulance]
  • R40.2232 Coma scale, best verbal response, inappropriate words, at arrival to emergency department
  • R40.2233 Coma scale, best verbal response, inappropriate words, at hospital admission
  • R40.2234 Coma scale, best verbal response, inappropriate words, 24 hours or more after hospital admission
  • R40.2240 Coma scale, best verbal response, confused conversation, unspecified time
  • R40.2241 Coma scale, best verbal response, confused conversation, in the field [EMT or ambulance]
  • R40.2242 Coma scale, best verbal response, confused conversation, at arrival to emergency department
  • R40.2243 Coma scale, best verbal response, confused conversation, at hospital admission
  • R40.2244 Coma scale, best verbal response, confused conversation, 24 hours or more after hospital admission
  • R40.2250 Coma scale, best verbal response, oriented, unspecified time
  • R40.2251 Coma scale, best verbal response, oriented, in the field [EMT or ambulance]
  • R40.2252 Coma scale, best verbal response, oriented, at arrival to emergency department
  • R40.2253 Coma scale, best verbal response, oriented, at hospital admission
  • R40.2254 Coma scale, best verbal response, oriented, 24 hours or more after hospital admission
  • R40.2310 Coma scale, best motor response, none, unspecified time
  • R40.2311 Coma scale, best motor response, none, in the field [EMT or ambulance]
  • R40.2312 Coma scale, best motor response, none, at arrival to emergency department
  • R40.2313 Coma scale, best motor response, none, at hospital admission
  • R40.2314 Coma scale, best motor response, none, 24 hours or more after hospital admission
  • R40.2320 Coma scale, best motor response, extension, unspecified time
  • R40.2321 Coma scale, best motor response, extension, in the field [EMT or ambulance]
  • R40.2322 Coma scale, best motor response, extension, at arrival to emergency department
  • R40.2323 Coma scale, best motor response, extension, at hospital admission
  • R40.2324 Coma scale, best motor response, extension, 24 hours or more after hospital admission
  • R40.2330 Coma scale, best motor response, abnormal flexion, unspecified time
  • R40.2331 Coma scale, best motor response, abnormal flexion, in the field [EMT or ambulance]
  • R40.2332 Coma scale, best motor response, abnormal flexion, at arrival to emergency department
  • R40.2333 Coma scale, best motor response, abnormal flexion, at hospital admission
  • R40.2334 Coma scale, best motor response, abnormal flexion, 24 hours or more after hospital admission
  • R40.2340 Coma scale, best motor response, flexion withdrawal, unspecified time
  • R40.2341 Coma scale, best motor response, flexion withdrawal, in the field [EMT or ambulance]
  • R40.2342 Coma scale, best motor response, flexion withdrawal, at arrival to emergency department
  • R40.2343 Coma scale, best motor response, flexion withdrawal, at hospital admission
  • R40.2344 Coma scale, best motor response, flexion withdrawal, 24 hours or more after hospital admission
  • R40.2350 Coma scale, best motor response, localizes pain, unspecified time
  • R40.2351 Coma scale, best motor response, localizes pain, in the field [EMT or ambulance]
  • R40.2352 Coma scale, best motor response, localizes pain, at arrival to emergency department
  • R40.2353 Coma scale, best motor response, localizes pain, at hospital admission
  • R40.2354 Coma scale, best motor response, localizes pain, 24 hours or more after hospital admission
  • R40.2360 Coma scale, best motor response, obeys commands, unspecified time
  • R40.2361 Coma scale, best motor response, obeys commands, in the field [EMT or ambulance]
  • R40.2362 Coma scale, best motor response, obeys commands, at arrival to emergency department
  • R40.2363 Coma scale, best motor response, obeys commands, at hospital admission
  • R40.2364 Coma scale, best motor response, obeys commands, 24 hours or more after hospital admission
  • R40.2410 Glasgow coma scale score 13-15, unspecified time
  • R40.2411 Glasgow coma scale score 13-15, in the field [EMT or ambulance]
  • R40.2412 Glasgow coma scale score 13-15, at arrival to emergency department
  • R40.2413 Glasgow coma scale score 13-15, at hospital admission
  • R40.2414 Glasgow coma scale score 13-15, 24 hours or more after hospital admission
  • R40.2420 Glasgow coma scale score 9-12, unspecified time
  • R40.2421 Glasgow coma scale score 9-12, in the field [EMT or ambulance]
  • R40.2422 Glasgow coma scale score 9-12, at arrival to emergency department
  • R40.2423 Glasgow coma scale score 9-12, at hospital admission
  • R40.2424 Glasgow coma scale score 9-12, 24 hours or more after hospital admission
  • R40.2430 Glasgow coma scale score 3-8, unspecified time
  • R40.2431 Glasgow coma scale score 3-8, in the field [EMT or ambulance]
  • R40.2432 Glasgow coma scale score 3-8, at arrival to emergency department
  • R40.2433 Glasgow coma scale score 3-8, at hospital admission
  • R40.2434 Glasgow coma scale score 3-8, 24 hours or more after hospital admission
  • R40.2440 Other coma, without documented Glasgow coma scale score, or with partial score reported, unspecified time
  • R40.2441 Other coma, without documented Glasgow coma scale score, or with partial score reported, in the field [EMT or ambulance]
  • R40.2442 Other coma, without documented Glasgow coma scale score, or with partial score reported, at arrival to emergency department
  • R40.2443 Other coma, without documented Glasgow coma scale score, or with partial score reported, at hospital admission
  • R40.2444 Other coma, without documented Glasgow coma scale score, or with partial score reported, 24 hours or more after hospital admission
  • R40.2A Nontraumatic coma due to underlying condition
R41 Other symptoms and signs involving cognitive functions and awareness1 code
  • R41.83 Borderline intellectual functioning
R45 Symptoms and signs involving emotional state1 code
R46 Symptoms and signs involving appearance and behavior2 codes
  • R46.81 Obsessive-compulsive behavior
  • R46.89 Other symptoms and signs involving appearance and behavior
R65 Symptoms and signs specifically associated with systemic inflammation and infection4 codes
  • R65.10 Systemic inflammatory response syndrome (SIRS) of non-infectious origin without acute organ dysfunction
  • R65.11 Systemic inflammatory response syndrome (SIRS) of non-infectious origin with acute organ dysfunction
  • R65.20 Severe sepsis without septic shock
  • R65.21 Severe sepsis with septic shock
S06 Intracranial injury6 codes
  • S06.A0XA Traumatic brain compression without herniation, initial encounter
  • S06.A0XD Traumatic brain compression without herniation, subsequent encounter
  • S06.A0XS Traumatic brain compression without herniation, sequela
  • S06.A1XA Traumatic brain compression with herniation, initial encounter
  • S06.A1XD Traumatic brain compression with herniation, subsequent encounter
  • S06.A1XS Traumatic brain compression with herniation, sequela
T36 Poisoning by, adverse effect of and underdosing of systemic antibiotics66 codes
  • T36.0X5A Adverse effect of penicillins, initial encounter
  • T36.0X5D Adverse effect of penicillins, subsequent encounter
  • T36.0X5S Adverse effect of penicillins, sequela
  • T36.0X6A Underdosing of penicillins, initial encounter
  • T36.0X6D Underdosing of penicillins, subsequent encounter
  • T36.0X6S Underdosing of penicillins, sequela
  • T36.1X5A Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
  • T36.1X5D Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
  • T36.1X5S Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela
  • T36.1X6A Underdosing of cephalosporins and other beta-lactam antibiotics, initial encounter
  • T36.1X6D Underdosing of cephalosporins and other beta-lactam antibiotics, subsequent encounter
  • T36.1X6S Underdosing of cephalosporins and other beta-lactam antibiotics, sequela
  • T36.2X5A Adverse effect of chloramphenicol group, initial encounter
  • T36.2X5D Adverse effect of chloramphenicol group, subsequent encounter
  • T36.2X5S Adverse effect of chloramphenicol group, sequela
  • T36.2X6A Underdosing of chloramphenicol group, initial encounter
  • T36.2X6D Underdosing of chloramphenicol group, subsequent encounter
  • T36.2X6S Underdosing of chloramphenicol group, sequela
  • T36.3X5A Adverse effect of macrolides, initial encounter
  • T36.3X5D Adverse effect of macrolides, subsequent encounter
  • T36.3X5S Adverse effect of macrolides, sequela
  • T36.3X6A Underdosing of macrolides, initial encounter
  • T36.3X6D Underdosing of macrolides, subsequent encounter
  • T36.3X6S Underdosing of macrolides, sequela
  • T36.4X5A Adverse effect of tetracyclines, initial encounter
  • T36.4X5D Adverse effect of tetracyclines, subsequent encounter
  • T36.4X5S Adverse effect of tetracyclines, sequela
  • T36.4X6A Underdosing of tetracyclines, initial encounter
  • T36.4X6D Underdosing of tetracyclines, subsequent encounter
  • T36.4X6S Underdosing of tetracyclines, sequela
  • T36.5X5A Adverse effect of aminoglycosides, initial encounter
  • T36.5X5D Adverse effect of aminoglycosides, subsequent encounter
  • T36.5X5S Adverse effect of aminoglycosides, sequela
  • T36.5X6A Underdosing of aminoglycosides, initial encounter
  • T36.5X6D Underdosing of aminoglycosides, subsequent encounter
  • T36.5X6S Underdosing of aminoglycosides, sequela
  • T36.6X5A Adverse effect of rifampicins, initial encounter
  • T36.6X5D Adverse effect of rifampicins, subsequent encounter
  • T36.6X5S Adverse effect of rifampicins, sequela
  • T36.6X6A Underdosing of rifampicins, initial encounter
  • T36.6X6D Underdosing of rifampicins, subsequent encounter
  • T36.6X6S Underdosing of rifampicins, sequela
  • T36.7X5A Adverse effect of antifungal antibiotics, systemically used, initial encounter
  • T36.7X5D Adverse effect of antifungal antibiotics, systemically used, subsequent encounter
  • T36.7X5S Adverse effect of antifungal antibiotics, systemically used, sequela
  • T36.7X6A Underdosing of antifungal antibiotics, systemically used, initial encounter
  • T36.7X6D Underdosing of antifungal antibiotics, systemically used, subsequent encounter
  • T36.7X6S Underdosing of antifungal antibiotics, systemically used, sequela
  • T36.8X5A Adverse effect of other systemic antibiotics, initial encounter
  • T36.8X5D Adverse effect of other systemic antibiotics, subsequent encounter
  • T36.8X5S Adverse effect of other systemic antibiotics, sequela
  • T36.8X6A Underdosing of other systemic antibiotics, initial encounter
  • T36.8X6D Underdosing of other systemic antibiotics, subsequent encounter
  • T36.8X6S Underdosing of other systemic antibiotics, sequela
  • T36.95XA Adverse effect of unspecified systemic antibiotic, initial encounter
  • T36.95XD Adverse effect of unspecified systemic antibiotic, subsequent encounter
  • T36.95XS Adverse effect of unspecified systemic antibiotic, sequela
  • T36.96XA Underdosing of unspecified systemic antibiotic, initial encounter
  • T36.96XD Underdosing of unspecified systemic antibiotic, subsequent encounter
  • T36.96XS Underdosing of unspecified systemic antibiotic, sequela
  • T36.AX5A Adverse effect of fluoroquinolone antibiotics, initial encounter
  • T36.AX5D Adverse effect of fluoroquinolone antibiotics, subsequent encounter
  • T36.AX5S Adverse effect of fluoroquinolone antibiotics, sequela
  • T36.AX6A Underdosing of fluoroquinolone antibiotics, initial encounter
  • T36.AX6D Underdosing of fluoroquinolone antibiotics, subsequent encounter
  • T36.AX6S Underdosing of fluoroquinolone antibiotics, sequela
T37 Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics48 codes
  • T37.0X5A Adverse effect of sulfonamides, initial encounter
  • T37.0X5D Adverse effect of sulfonamides, subsequent encounter
  • T37.0X5S Adverse effect of sulfonamides, sequela
  • T37.0X6A Underdosing of sulfonamides, initial encounter
  • T37.0X6D Underdosing of sulfonamides, subsequent encounter
  • T37.0X6S Underdosing of sulfonamides, sequela
  • T37.1X5A Adverse effect of antimycobacterial drugs, initial encounter
  • T37.1X5D Adverse effect of antimycobacterial drugs, subsequent encounter
  • T37.1X5S Adverse effect of antimycobacterial drugs, sequela
  • T37.1X6A Underdosing of antimycobacterial drugs, initial encounter
  • T37.1X6D Underdosing of antimycobacterial drugs, subsequent encounter
  • T37.1X6S Underdosing of antimycobacterial drugs, sequela
  • T37.2X5A Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
  • T37.2X5D Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
  • T37.2X5S Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela
  • T37.2X6A Underdosing of antimalarials and drugs acting on other blood protozoa, initial encounter
  • T37.2X6D Underdosing of antimalarials and drugs acting on other blood protozoa, subsequent encounter
  • T37.2X6S Underdosing of antimalarials and drugs acting on other blood protozoa, sequela
  • T37.3X5A Adverse effect of other antiprotozoal drugs, initial encounter
  • T37.3X5D Adverse effect of other antiprotozoal drugs, subsequent encounter
  • T37.3X5S Adverse effect of other antiprotozoal drugs, sequela
  • T37.3X6A Underdosing of other antiprotozoal drugs, initial encounter
  • T37.3X6D Underdosing of other antiprotozoal drugs, subsequent encounter
  • T37.3X6S Underdosing of other antiprotozoal drugs, sequela
  • T37.4X5A Adverse effect of anthelminthics, initial encounter
  • T37.4X5D Adverse effect of anthelminthics, subsequent encounter
  • T37.4X5S Adverse effect of anthelminthics, sequela
  • T37.4X6A Underdosing of anthelminthics, initial encounter
  • T37.4X6D Underdosing of anthelminthics, subsequent encounter
  • T37.4X6S Underdosing of anthelminthics, sequela
  • T37.5X5A Adverse effect of antiviral drugs, initial encounter
  • T37.5X5D Adverse effect of antiviral drugs, subsequent encounter
  • T37.5X5S Adverse effect of antiviral drugs, sequela
  • T37.5X6A Underdosing of antiviral drugs, initial encounter
  • T37.5X6D Underdosing of antiviral drugs, subsequent encounter
  • T37.5X6S Underdosing of antiviral drugs, sequela
  • T37.8X5A Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
  • T37.8X5D Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
  • T37.8X5S Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
  • T37.8X6A Underdosing of other specified systemic anti-infectives and antiparasitics, initial encounter
  • T37.8X6D Underdosing of other specified systemic anti-infectives and antiparasitics, subsequent encounter
  • T37.8X6S Underdosing of other specified systemic anti-infectives and antiparasitics, sequela
  • T37.95XA Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
  • T37.95XD Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
  • T37.95XS Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela
  • T37.96XA Underdosing of unspecified systemic anti-infectives and antiparasitics, initial encounter
  • T37.96XD Underdosing of unspecified systemic anti-infectives and antiparasitics, subsequent encounter
  • T37.96XS Underdosing of unspecified systemic anti-infectives and antiparasitics, sequela
T38 Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified78 codes
  • T38.0X5A Adverse effect of glucocorticoids and synthetic analogues, initial encounter
  • T38.0X5D Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter
  • T38.0X5S Adverse effect of glucocorticoids and synthetic analogues, sequela
  • T38.0X6A Underdosing of glucocorticoids and synthetic analogues, initial encounter
  • T38.0X6D Underdosing of glucocorticoids and synthetic analogues, subsequent encounter
  • T38.0X6S Underdosing of glucocorticoids and synthetic analogues, sequela
  • T38.1X5A Adverse effect of thyroid hormones and substitutes, initial encounter
  • T38.1X5D Adverse effect of thyroid hormones and substitutes, subsequent encounter
  • T38.1X5S Adverse effect of thyroid hormones and substitutes, sequela
  • T38.1X6A Underdosing of thyroid hormones and substitutes, initial encounter
  • T38.1X6D Underdosing of thyroid hormones and substitutes, subsequent encounter
  • T38.1X6S Underdosing of thyroid hormones and substitutes, sequela
  • T38.2X5A Adverse effect of antithyroid drugs, initial encounter
  • T38.2X5D Adverse effect of antithyroid drugs, subsequent encounter
  • T38.2X5S Adverse effect of antithyroid drugs, sequela
  • T38.2X6A Underdosing of antithyroid drugs, initial encounter
  • T38.2X6D Underdosing of antithyroid drugs, subsequent encounter
  • T38.2X6S Underdosing of antithyroid drugs, sequela
  • T38.3X5A Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
  • T38.3X5D Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
  • T38.3X5S Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
  • T38.3X6A Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter
  • T38.3X6D Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter
  • T38.3X6S Underdosing of insulin and oral hypoglycemic [antidiabetic] drugs, sequela
  • T38.4X5A Adverse effect of oral contraceptives, initial encounter
  • T38.4X5D Adverse effect of oral contraceptives, subsequent encounter
  • T38.4X5S Adverse effect of oral contraceptives, sequela
  • T38.4X6A Underdosing of oral contraceptives, initial encounter
  • T38.4X6D Underdosing of oral contraceptives, subsequent encounter
  • T38.4X6S Underdosing of oral contraceptives, sequela
  • T38.5X5A Adverse effect of other estrogens and progestogens, initial encounter
  • T38.5X5D Adverse effect of other estrogens and progestogens, subsequent encounter
  • T38.5X5S Adverse effect of other estrogens and progestogens, sequela
  • T38.5X6A Underdosing of other estrogens and progestogens, initial encounter
  • T38.5X6D Underdosing of other estrogens and progestogens, subsequent encounter
  • T38.5X6S Underdosing of other estrogens and progestogens, sequela
  • T38.6X5A Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
  • T38.6X5D Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
  • T38.6X5S Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
  • T38.6X6A Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
  • T38.6X6D Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
  • T38.6X6S Underdosing of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
  • T38.7X5A Adverse effect of androgens and anabolic congeners, initial encounter
  • T38.7X5D Adverse effect of androgens and anabolic congeners, subsequent encounter
  • T38.7X5S Adverse effect of androgens and anabolic congeners, sequela
  • T38.7X6A Underdosing of androgens and anabolic congeners, initial encounter
  • T38.7X6D Underdosing of androgens and anabolic congeners, subsequent encounter
  • T38.7X6S Underdosing of androgens and anabolic congeners, sequela
  • T38.805A Adverse effect of unspecified hormones and synthetic substitutes, initial encounter
  • T38.805D Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
  • T38.805S Adverse effect of unspecified hormones and synthetic substitutes, sequela
  • T38.806A Underdosing of unspecified hormones and synthetic substitutes, initial encounter
  • T38.806D Underdosing of unspecified hormones and synthetic substitutes, subsequent encounter
  • T38.806S Underdosing of unspecified hormones and synthetic substitutes, sequela
  • T38.815A Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
  • T38.815D Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
  • T38.815S Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
  • T38.816A Underdosing of anterior pituitary [adenohypophyseal] hormones, initial encounter
  • T38.816D Underdosing of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
  • T38.816S Underdosing of anterior pituitary [adenohypophyseal] hormones, sequela
  • T38.895A Adverse effect of other hormones and synthetic substitutes, initial encounter
  • T38.895D Adverse effect of other hormones and synthetic substitutes, subsequent encounter
  • T38.895S Adverse effect of other hormones and synthetic substitutes, sequela
  • T38.896A Underdosing of other hormones and synthetic substitutes, initial encounter
  • T38.896D Underdosing of other hormones and synthetic substitutes, subsequent encounter
  • T38.896S Underdosing of other hormones and synthetic substitutes, sequela
  • T38.905A Adverse effect of unspecified hormone antagonists, initial encounter
  • T38.905D Adverse effect of unspecified hormone antagonists, subsequent encounter
  • T38.905S Adverse effect of unspecified hormone antagonists, sequela
  • T38.906A Underdosing of unspecified hormone antagonists, initial encounter
  • T38.906D Underdosing of unspecified hormone antagonists, subsequent encounter
  • T38.906S Underdosing of unspecified hormone antagonists, sequela
  • T38.995A Adverse effect of other hormone antagonists, initial encounter
  • T38.995D Adverse effect of other hormone antagonists, subsequent encounter
  • T38.995S Adverse effect of other hormone antagonists, sequela
  • T38.996A Underdosing of other hormone antagonists, initial encounter
  • T38.996D Underdosing of other hormone antagonists, subsequent encounter
  • T38.996S Underdosing of other hormone antagonists, sequela
T39 Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics54 codes
  • T39.015A Adverse effect of aspirin, initial encounter
  • T39.015D Adverse effect of aspirin, subsequent encounter
  • T39.015S Adverse effect of aspirin, sequela
  • T39.016A Underdosing of aspirin, initial encounter
  • T39.016D Underdosing of aspirin, subsequent encounter
  • T39.016S Underdosing of aspirin, sequela
  • T39.095A Adverse effect of salicylates, initial encounter
  • T39.095D Adverse effect of salicylates, subsequent encounter
  • T39.095S Adverse effect of salicylates, sequela
  • T39.096A Underdosing of salicylates, initial encounter
  • T39.096D Underdosing of salicylates, subsequent encounter
  • T39.096S Underdosing of salicylates, sequela
  • T39.1X5A Adverse effect of 4-Aminophenol derivatives, initial encounter
  • T39.1X5D Adverse effect of 4-Aminophenol derivatives, subsequent encounter
  • T39.1X5S Adverse effect of 4-Aminophenol derivatives, sequela
  • T39.1X6A Underdosing of 4-Aminophenol derivatives, initial encounter
  • T39.1X6D Underdosing of 4-Aminophenol derivatives, subsequent encounter
  • T39.1X6S Underdosing of 4-Aminophenol derivatives, sequela
  • T39.2X5A Adverse effect of pyrazolone derivatives, initial encounter
  • T39.2X5D Adverse effect of pyrazolone derivatives, subsequent encounter
  • T39.2X5S Adverse effect of pyrazolone derivatives, sequela
  • T39.2X6A Underdosing of pyrazolone derivatives, initial encounter
  • T39.2X6D Underdosing of pyrazolone derivatives, subsequent encounter
  • T39.2X6S Underdosing of pyrazolone derivatives, sequela
  • T39.315A Adverse effect of propionic acid derivatives, initial encounter
  • T39.315D Adverse effect of propionic acid derivatives, subsequent encounter
  • T39.315S Adverse effect of propionic acid derivatives, sequela
  • T39.316A Underdosing of propionic acid derivatives, initial encounter
  • T39.316D Underdosing of propionic acid derivatives, subsequent encounter
  • T39.316S Underdosing of propionic acid derivatives, sequela
  • T39.395A Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
  • T39.395D Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
  • T39.395S Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
  • T39.396A Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
  • T39.396D Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
  • T39.396S Underdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
  • T39.4X5A Adverse effect of antirheumatics, not elsewhere classified, initial encounter
  • T39.4X5D Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter
  • T39.4X5S Adverse effect of antirheumatics, not elsewhere classified, sequela
  • T39.4X6A Underdosing of antirheumatics, not elsewhere classified, initial encounter
  • T39.4X6D Underdosing of antirheumatics, not elsewhere classified, subsequent encounter
  • T39.4X6S Underdosing of antirheumatics, not elsewhere classified, sequela
  • T39.8X5A Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
  • T39.8X5D Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
  • T39.8X5S Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
  • T39.8X6A Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
  • T39.8X6D Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
  • T39.8X6S Underdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
  • T39.95XA Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
  • T39.95XD Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
  • T39.95XS Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
  • T39.96XA Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
  • T39.96XD Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
  • T39.96XS Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
T40 Poisoning by, adverse effect of and underdosing of narcotics and psychodysleptics [hallucinogens]78 codes
  • T40.0X5A Adverse effect of opium, initial encounter
  • T40.0X5D Adverse effect of opium, subsequent encounter
  • T40.0X5S Adverse effect of opium, sequela
  • T40.0X6A Underdosing of opium, initial encounter
  • T40.0X6D Underdosing of opium, subsequent encounter
  • T40.0X6S Underdosing of opium, sequela
  • T40.2X5A Adverse effect of other opioids, initial encounter
  • T40.2X5D Adverse effect of other opioids, subsequent encounter
  • T40.2X5S Adverse effect of other opioids, sequela
  • T40.2X6A Underdosing of other opioids, initial encounter
  • T40.2X6D Underdosing of other opioids, subsequent encounter
  • T40.2X6S Underdosing of other opioids, sequela
  • T40.3X5A Adverse effect of methadone, initial encounter
  • T40.3X5D Adverse effect of methadone, subsequent encounter
  • T40.3X5S Adverse effect of methadone, sequela
  • T40.3X6A Underdosing of methadone, initial encounter
  • T40.3X6D Underdosing of methadone, subsequent encounter
  • T40.3X6S Underdosing of methadone, sequela
  • T40.415A Adverse effect of fentanyl or fentanyl analogs, initial encounter
  • T40.415D Adverse effect of fentanyl or fentanyl analogs, subsequent encounter
  • T40.415S Adverse effect of fentanyl or fentanyl analogs, sequela
  • T40.416A Underdosing of fentanyl or fentanyl analogs, initial encounter
  • T40.416D Underdosing of fentanyl or fentanyl analogs, subsequent encounter
  • T40.416S Underdosing of fentanyl or fentanyl analogs, sequela
  • T40.425A Adverse effect of tramadol, initial encounter
  • T40.425D Adverse effect of tramadol, subsequent encounter
  • T40.425S Adverse effect of tramadol, sequela
  • T40.426A Underdosing of tramadol, initial encounter
  • T40.426D Underdosing of tramadol, subsequent encounter
  • T40.426S Underdosing of tramadol, sequela
  • T40.495A Adverse effect of other synthetic narcotics, initial encounter
  • T40.495D Adverse effect of other synthetic narcotics, subsequent encounter
  • T40.495S Adverse effect of other synthetic narcotics, sequela
  • T40.496A Underdosing of other synthetic narcotics, initial encounter
  • T40.496D Underdosing of other synthetic narcotics, subsequent encounter
  • T40.496S Underdosing of other synthetic narcotics, sequela
  • T40.5X5A Adverse effect of cocaine, initial encounter
  • T40.5X5D Adverse effect of cocaine, subsequent encounter
  • T40.5X5S Adverse effect of cocaine, sequela
  • T40.5X6A Underdosing of cocaine, initial encounter
  • T40.5X6D Underdosing of cocaine, subsequent encounter
  • T40.5X6S Underdosing of cocaine, sequela
  • T40.605A Adverse effect of unspecified narcotics, initial encounter
  • T40.605D Adverse effect of unspecified narcotics, subsequent encounter
  • T40.605S Adverse effect of unspecified narcotics, sequela
  • T40.606A Underdosing of unspecified narcotics, initial encounter
  • T40.606D Underdosing of unspecified narcotics, subsequent encounter
  • T40.606S Underdosing of unspecified narcotics, sequela
  • T40.695A Adverse effect of other narcotics, initial encounter
  • T40.695D Adverse effect of other narcotics, subsequent encounter
  • T40.695S Adverse effect of other narcotics, sequela
  • T40.696A Underdosing of other narcotics, initial encounter
  • T40.696D Underdosing of other narcotics, subsequent encounter
  • T40.696S Underdosing of other narcotics, sequela
  • T40.715A Adverse effect of cannabis, initial encounter
  • T40.715D Adverse effect of cannabis, subsequent encounter
  • T40.715S Adverse effect of cannabis, sequela
  • T40.716A Underdosing of cannabis, initial encounter
  • T40.716D Underdosing of cannabis, subsequent encounter
  • T40.716S Underdosing of cannabis, sequela
  • T40.725A Adverse effect of synthetic cannabinoids, initial encounter
  • T40.725D Adverse effect of synthetic cannabinoids, subsequent encounter
  • T40.725S Adverse effect of synthetic cannabinoids, sequela
  • T40.726A Underdosing of synthetic cannabinoids, initial encounter
  • T40.726D Underdosing of synthetic cannabinoids, subsequent encounter
  • T40.726S Underdosing of synthetic cannabinoids, sequela
  • T40.905A Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
  • T40.905D Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
  • T40.905S Adverse effect of unspecified psychodysleptics [hallucinogens], sequela
  • T40.906A Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter
  • T40.906D Underdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter
  • T40.906S Underdosing of unspecified psychodysleptics [hallucinogens], sequela
  • T40.995A Adverse effect of other psychodysleptics [hallucinogens], initial encounter
  • T40.995D Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
  • T40.995S Adverse effect of other psychodysleptics [hallucinogens], sequela
  • T40.996A Underdosing of other psychodysleptics [hallucinogens], initial encounter
  • T40.996D Underdosing of other psychodysleptics [hallucinogens], subsequent encounter
  • T40.996S Underdosing of other psychodysleptics [hallucinogens], sequela
T41 Poisoning by, adverse effect of and underdosing of anesthetics and therapeutic gases42 codes
  • T41.0X5A Adverse effect of inhaled anesthetics, initial encounter
  • T41.0X5D Adverse effect of inhaled anesthetics, subsequent encounter
  • T41.0X5S Adverse effect of inhaled anesthetics, sequela
  • T41.0X6A Underdosing of inhaled anesthetics, initial encounter
  • T41.0X6D Underdosing of inhaled anesthetics, subsequent encounter
  • T41.0X6S Underdosing of inhaled anesthetics, sequela
  • T41.1X5A Adverse effect of intravenous anesthetics, initial encounter
  • T41.1X5D Adverse effect of intravenous anesthetics, subsequent encounter
  • T41.1X5S Adverse effect of intravenous anesthetics, sequela
  • T41.1X6A Underdosing of intravenous anesthetics, initial encounter
  • T41.1X6D Underdosing of intravenous anesthetics, subsequent encounter
  • T41.1X6S Underdosing of intravenous anesthetics, sequela
  • T41.205A Adverse effect of unspecified general anesthetics, initial encounter
  • T41.205D Adverse effect of unspecified general anesthetics, subsequent encounter
  • T41.205S Adverse effect of unspecified general anesthetics, sequela
  • T41.206A Underdosing of unspecified general anesthetics, initial encounter
  • T41.206D Underdosing of unspecified general anesthetics, subsequent encounter
  • T41.206S Underdosing of unspecified general anesthetics, sequela
  • T41.295A Adverse effect of other general anesthetics, initial encounter
  • T41.295D Adverse effect of other general anesthetics, subsequent encounter
  • T41.295S Adverse effect of other general anesthetics, sequela
  • T41.296A Underdosing of other general anesthetics, initial encounter
  • T41.296D Underdosing of other general anesthetics, subsequent encounter
  • T41.296S Underdosing of other general anesthetics, sequela
  • T41.3X5A Adverse effect of local anesthetics, initial encounter
  • T41.3X5D Adverse effect of local anesthetics, subsequent encounter
  • T41.3X5S Adverse effect of local anesthetics, sequela
  • T41.3X6A Underdosing of local anesthetics, initial encounter
  • T41.3X6D Underdosing of local anesthetics, subsequent encounter
  • T41.3X6S Underdosing of local anesthetics, sequela
  • T41.45XA Adverse effect of unspecified anesthetic, initial encounter
  • T41.45XD Adverse effect of unspecified anesthetic, subsequent encounter
  • T41.45XS Adverse effect of unspecified anesthetic, sequela
  • T41.46XA Underdosing of unspecified anesthetics, initial encounter
  • T41.46XD Underdosing of unspecified anesthetics, subsequent encounter
  • T41.46XS Underdosing of unspecified anesthetics, sequela
  • T41.5X5A Adverse effect of therapeutic gases, initial encounter
  • T41.5X5D Adverse effect of therapeutic gases, subsequent encounter
  • T41.5X5S Adverse effect of therapeutic gases, sequela
  • T41.5X6A Underdosing of therapeutic gases, initial encounter
  • T41.5X6D Underdosing of therapeutic gases, subsequent encounter
  • T41.5X6S Underdosing of therapeutic gases, sequela
T42 Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs54 codes
  • T42.0X5A Adverse effect of hydantoin derivatives, initial encounter
  • T42.0X5D Adverse effect of hydantoin derivatives, subsequent encounter
  • T42.0X5S Adverse effect of hydantoin derivatives, sequela
  • T42.0X6A Underdosing of hydantoin derivatives, initial encounter
  • T42.0X6D Underdosing of hydantoin derivatives, subsequent encounter
  • T42.0X6S Underdosing of hydantoin derivatives, sequela
  • T42.1X5A Adverse effect of iminostilbenes, initial encounter
  • T42.1X5D Adverse effect of iminostilbenes, subsequent encounter
  • T42.1X5S Adverse effect of iminostilbenes, sequela
  • T42.1X6A Underdosing of iminostilbenes, initial encounter
  • T42.1X6D Underdosing of iminostilbenes, subsequent encounter
  • T42.1X6S Underdosing of iminostilbenes, sequela
  • T42.2X5A Adverse effect of succinimides and oxazolidinediones, initial encounter
  • T42.2X5D Adverse effect of succinimides and oxazolidinediones, subsequent encounter
  • T42.2X5S Adverse effect of succinimides and oxazolidinediones, sequela
  • T42.2X6A Underdosing of succinimides and oxazolidinediones, initial encounter
  • T42.2X6D Underdosing of succinimides and oxazolidinediones, subsequent encounter
  • T42.2X6S Underdosing of succinimides and oxazolidinediones, sequela
  • T42.3X5A Adverse effect of barbiturates, initial encounter
  • T42.3X5D Adverse effect of barbiturates, subsequent encounter
  • T42.3X5S Adverse effect of barbiturates, sequela
  • T42.3X6A Underdosing of barbiturates, initial encounter
  • T42.3X6D Underdosing of barbiturates, subsequent encounter
  • T42.3X6S Underdosing of barbiturates, sequela
  • T42.4X5A Adverse effect of benzodiazepines, initial encounter
  • T42.4X5D Adverse effect of benzodiazepines, subsequent encounter
  • T42.4X5S Adverse effect of benzodiazepines, sequela
  • T42.4X6A Underdosing of benzodiazepines, initial encounter
  • T42.4X6D Underdosing of benzodiazepines, subsequent encounter
  • T42.4X6S Underdosing of benzodiazepines, sequela
  • T42.5X5A Adverse effect of mixed antiepileptics, initial encounter
  • T42.5X5D Adverse effect of mixed antiepileptics, subsequent encounter
  • T42.5X5S Adverse effect of mixed antiepileptics, sequela
  • T42.5X6A Underdosing of mixed antiepileptics, initial encounter
  • T42.5X6D Underdosing of mixed antiepileptics, subsequent encounter
  • T42.5X6S Underdosing of mixed antiepileptics, sequela
  • T42.6X5A Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
  • T42.6X5D Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
  • T42.6X5S Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
  • T42.6X6A Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter
  • T42.6X6D Underdosing of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
  • T42.6X6S Underdosing of other antiepileptic and sedative-hypnotic drugs, sequela
  • T42.75XA Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
  • T42.75XD Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
  • T42.75XS Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
  • T42.76XA Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
  • T42.76XD Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
  • T42.76XS Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, sequela
  • T42.8X5A Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
  • T42.8X5D Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
  • T42.8X5S Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
  • T42.8X6A Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
  • T42.8X6D Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
  • T42.8X6S Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, sequela
T43 Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified114 codes
  • T43.015A Adverse effect of tricyclic antidepressants, initial encounter
  • T43.015D Adverse effect of tricyclic antidepressants, subsequent encounter
  • T43.015S Adverse effect of tricyclic antidepressants, sequela
  • T43.016A Underdosing of tricyclic antidepressants, initial encounter
  • T43.016D Underdosing of tricyclic antidepressants, subsequent encounter
  • T43.016S Underdosing of tricyclic antidepressants, sequela
  • T43.025A Adverse effect of tetracyclic antidepressants, initial encounter
  • T43.025D Adverse effect of tetracyclic antidepressants, subsequent encounter
  • T43.025S Adverse effect of tetracyclic antidepressants, sequela
  • T43.026A Underdosing of tetracyclic antidepressants, initial encounter
  • T43.026D Underdosing of tetracyclic antidepressants, subsequent encounter
  • T43.026S Underdosing of tetracyclic antidepressants, sequela
  • T43.1X5A Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
  • T43.1X5D Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
  • T43.1X5S Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
  • T43.1X6A Underdosing of monoamine-oxidase-inhibitor antidepressants, initial encounter
  • T43.1X6D Underdosing of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
  • T43.1X6S Underdosing of monoamine-oxidase-inhibitor antidepressants, sequela
  • T43.205A Adverse effect of unspecified antidepressants, initial encounter
  • T43.205D Adverse effect of unspecified antidepressants, subsequent encounter
  • T43.205S Adverse effect of unspecified antidepressants, sequela
  • T43.206A Underdosing of unspecified antidepressants, initial encounter
  • T43.206D Underdosing of unspecified antidepressants, subsequent encounter
  • T43.206S Underdosing of unspecified antidepressants, sequela
  • T43.215A Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
  • T43.215D Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
  • T43.215S Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
  • T43.216A Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
  • T43.216D Underdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
  • T43.216S Underdosing of selective serotonin and norepinephrine reuptake inhibitors, sequela
  • T43.225A Adverse effect of selective serotonin reuptake inhibitors, initial encounter
  • T43.225D Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
  • T43.225S Adverse effect of selective serotonin reuptake inhibitors, sequela
  • T43.226A Underdosing of selective serotonin reuptake inhibitors, initial encounter
  • T43.226D Underdosing of selective serotonin reuptake inhibitors, subsequent encounter
  • T43.226S Underdosing of selective serotonin reuptake inhibitors, sequela
  • T43.295A Adverse effect of other antidepressants, initial encounter
  • T43.295D Adverse effect of other antidepressants, subsequent encounter
  • T43.295S Adverse effect of other antidepressants, sequela
  • T43.296A Underdosing of other antidepressants, initial encounter
  • T43.296D Underdosing of other antidepressants, subsequent encounter
  • T43.296S Underdosing of other antidepressants, sequela
  • T43.3X5A Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
  • T43.3X5D Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
  • T43.3X5S Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
  • T43.3X6A Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter
  • T43.3X6D Underdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounter
  • T43.3X6S Underdosing of phenothiazine antipsychotics and neuroleptics, sequela
  • T43.4X5A Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
  • T43.4X5D Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
  • T43.4X5S Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
  • T43.4X6A Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter
  • T43.4X6D Underdosing of butyrophenone and thiothixene neuroleptics, subsequent encounter
  • T43.4X6S Underdosing of butyrophenone and thiothixene neuroleptics, sequela
  • T43.505A Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
  • T43.505D Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
  • T43.505S Adverse effect of unspecified antipsychotics and neuroleptics, sequela
  • T43.506A Underdosing of unspecified antipsychotics and neuroleptics, initial encounter
  • T43.506D Underdosing of unspecified antipsychotics and neuroleptics, subsequent encounter
  • T43.506S Underdosing of unspecified antipsychotics and neuroleptics, sequela
  • T43.595A Adverse effect of other antipsychotics and neuroleptics, initial encounter
  • T43.595D Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
  • T43.595S Adverse effect of other antipsychotics and neuroleptics, sequela
  • T43.596A Underdosing of other antipsychotics and neuroleptics, initial encounter
  • T43.596D Underdosing of other antipsychotics and neuroleptics, subsequent encounter
  • T43.596S Underdosing of other antipsychotics and neuroleptics, sequela
  • T43.605A Adverse effect of unspecified psychostimulants, initial encounter
  • T43.605D Adverse effect of unspecified psychostimulants, subsequent encounter
  • T43.605S Adverse effect of unspecified psychostimulants, sequela
  • T43.606A Underdosing of unspecified psychostimulants, initial encounter
  • T43.606D Underdosing of unspecified psychostimulants, subsequent encounter
  • T43.606S Underdosing of unspecified psychostimulants, sequela
  • T43.615A Adverse effect of caffeine, initial encounter
  • T43.615D Adverse effect of caffeine, subsequent encounter
  • T43.615S Adverse effect of caffeine, sequela
  • T43.616A Underdosing of caffeine, initial encounter
  • T43.616D Underdosing of caffeine, subsequent encounter
  • T43.616S Underdosing of caffeine, sequela
  • T43.625A Adverse effect of amphetamines, initial encounter
  • T43.625D Adverse effect of amphetamines, subsequent encounter
  • T43.625S Adverse effect of amphetamines, sequela
  • T43.626A Underdosing of amphetamines, initial encounter
  • T43.626D Underdosing of amphetamines, subsequent encounter
  • T43.626S Underdosing of amphetamines, sequela
  • T43.635A Adverse effect of methylphenidate, initial encounter
  • T43.635D Adverse effect of methylphenidate, subsequent encounter
  • T43.635S Adverse effect of methylphenidate, sequela
  • T43.636A Underdosing of methylphenidate, initial encounter
  • T43.636D Underdosing of methylphenidate, subsequent encounter
  • T43.636S Underdosing of methylphenidate, sequela
  • T43.655A Adverse effect of methamphetamines, initial encounter
  • T43.655D Adverse effect of methamphetamines, subsequent encounter
  • T43.655S Adverse effect of methamphetamines, sequela
  • T43.656A Underdosing of methamphetamines, initial encounter
  • T43.656D Underdosing of methamphetamines, subsequent encounter
  • T43.656S Underdosing of methamphetamines, sequela
  • T43.695A Adverse effect of other psychostimulants, initial encounter
  • T43.695D Adverse effect of other psychostimulants, subsequent encounter
  • T43.695S Adverse effect of other psychostimulants, sequela
  • T43.696A Underdosing of other psychostimulants, initial encounter
  • T43.696D Underdosing of other psychostimulants, subsequent encounter
  • T43.696S Underdosing of other psychostimulants, sequela
  • T43.8X5A Adverse effect of other psychotropic drugs, initial encounter
  • T43.8X5D Adverse effect of other psychotropic drugs, subsequent encounter
  • T43.8X5S Adverse effect of other psychotropic drugs, sequela
  • T43.8X6A Underdosing of other psychotropic drugs, initial encounter
  • T43.8X6D Underdosing of other psychotropic drugs, subsequent encounter
  • T43.8X6S Underdosing of other psychotropic drugs, sequela
  • T43.95XA Adverse effect of unspecified psychotropic drug, initial encounter
  • T43.95XD Adverse effect of unspecified psychotropic drug, subsequent encounter
  • T43.95XS Adverse effect of unspecified psychotropic drug, sequela
  • T43.96XA Underdosing of unspecified psychotropic drug, initial encounter
  • T43.96XD Underdosing of unspecified psychotropic drug, subsequent encounter
  • T43.96XS Underdosing of unspecified psychotropic drug, sequela
T44 Poisoning by, adverse effect of and underdosing of drugs primarily affecting the autonomic nervous system66 codes
  • T44.0X5A Adverse effect of anticholinesterase agents, initial encounter
  • T44.0X5D Adverse effect of anticholinesterase agents, subsequent encounter
  • T44.0X5S Adverse effect of anticholinesterase agents, sequela
  • T44.0X6A Underdosing of anticholinesterase agents, initial encounter
  • T44.0X6D Underdosing of anticholinesterase agents, subsequent encounter
  • T44.0X6S Underdosing of anticholinesterase agents, sequela
  • T44.1X5A Adverse effect of other parasympathomimetics [cholinergics], initial encounter
  • T44.1X5D Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
  • T44.1X5S Adverse effect of other parasympathomimetics [cholinergics], sequela
  • T44.1X6A Underdosing of other parasympathomimetics [cholinergics], initial encounter
  • T44.1X6D Underdosing of other parasympathomimetics [cholinergics], subsequent encounter
  • T44.1X6S Underdosing of other parasympathomimetics [cholinergics], sequela
  • T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter
  • T44.2X5D Adverse effect of ganglionic blocking drugs, subsequent encounter
  • T44.2X5S Adverse effect of ganglionic blocking drugs, sequela
  • T44.2X6A Underdosing of ganglionic blocking drugs, initial encounter
  • T44.2X6D Underdosing of ganglionic blocking drugs, subsequent encounter
  • T44.2X6S Underdosing of ganglionic blocking drugs, sequela
  • T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
  • T44.3X5D Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
  • T44.3X5S Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
  • T44.3X6A Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
  • T44.3X6D Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
  • T44.3X6S Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
  • T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
  • T44.4X5D Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
  • T44.4X5S Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
  • T44.4X6A Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter
  • T44.4X6D Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter
  • T44.4X6S Underdosing of predominantly alpha-adrenoreceptor agonists, sequela
  • T44.5X5A Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
  • T44.5X5D Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
  • T44.5X5S Adverse effect of predominantly beta-adrenoreceptor agonists, sequela
  • T44.5X6A Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter
  • T44.5X6D Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter
  • T44.5X6S Underdosing of predominantly beta-adrenoreceptor agonists, sequela
  • T44.6X5A Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
  • T44.6X5D Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
  • T44.6X5S Adverse effect of alpha-adrenoreceptor antagonists, sequela
  • T44.6X6A Underdosing of alpha-adrenoreceptor antagonists, initial encounter
  • T44.6X6D Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter
  • T44.6X6S Underdosing of alpha-adrenoreceptor antagonists, sequela
  • T44.7X5A Adverse effect of beta-adrenoreceptor antagonists, initial encounter
  • T44.7X5D Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter
  • T44.7X5S Adverse effect of beta-adrenoreceptor antagonists, sequela
  • T44.7X6A Underdosing of beta-adrenoreceptor antagonists, initial encounter
  • T44.7X6D Underdosing of beta-adrenoreceptor antagonists, subsequent encounter
  • T44.7X6S Underdosing of beta-adrenoreceptor antagonists, sequela
  • T44.8X5A Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
  • T44.8X5D Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
  • T44.8X5S Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
  • T44.8X6A Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
  • T44.8X6D Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
  • T44.8X6S Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela
  • T44.905A Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
  • T44.905D Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
  • T44.905S Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
  • T44.906A Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
  • T44.906D Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
  • T44.906S Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela
  • T44.995A Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter
  • T44.995D Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter
  • T44.995S Adverse effect of other drug primarily affecting the autonomic nervous system, sequela
  • T44.996A Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter
  • T44.996D Underdosing of other drug primarily affecting the autonomic nervous system, subsequent encounter
  • T44.996S Underdosing of other drug primarily affecting the autonomic nervous system, sequela
T45 Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified84 codes
  • T45.0X5A Adverse effect of antiallergic and antiemetic drugs, initial encounter
  • T45.0X5D Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
  • T45.0X5S Adverse effect of antiallergic and antiemetic drugs, sequela
  • T45.0X6A Underdosing of antiallergic and antiemetic drugs, initial encounter
  • T45.0X6D Underdosing of antiallergic and antiemetic drugs, subsequent encounter
  • T45.0X6S Underdosing of antiallergic and antiemetic drugs, sequela
  • T45.1X5A Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
  • T45.1X5D Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
  • T45.1X5S Adverse effect of antineoplastic and immunosuppressive drugs, sequela
  • T45.1X6A Underdosing of antineoplastic and immunosuppressive drugs, initial encounter
  • T45.1X6D Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter
  • T45.1X6S Underdosing of antineoplastic and immunosuppressive drugs, sequela
  • T45.2X5A Adverse effect of vitamins, initial encounter
  • T45.2X5D Adverse effect of vitamins, subsequent encounter
  • T45.2X5S Adverse effect of vitamins, sequela
  • T45.2X6A Underdosing of vitamins, initial encounter
  • T45.2X6D Underdosing of vitamins, subsequent encounter
  • T45.2X6S Underdosing of vitamins, sequela
  • T45.3X5A Adverse effect of enzymes, initial encounter
  • T45.3X5D Adverse effect of enzymes, subsequent encounter
  • T45.3X5S Adverse effect of enzymes, sequela
  • T45.3X6A Underdosing of enzymes, initial encounter
  • T45.3X6D Underdosing of enzymes, subsequent encounter
  • T45.3X6S Underdosing of enzymes, sequela
  • T45.4X5A Adverse effect of iron and its compounds, initial encounter
  • T45.4X5D Adverse effect of iron and its compounds, subsequent encounter
  • T45.4X5S Adverse effect of iron and its compounds, sequela
  • T45.4X6A Underdosing of iron and its compounds, initial encounter
  • T45.4X6D Underdosing of iron and its compounds, subsequent encounter
  • T45.4X6S Underdosing of iron and its compounds, sequela
  • T45.515A Adverse effect of anticoagulants, initial encounter
  • T45.515D Adverse effect of anticoagulants, subsequent encounter
  • T45.515S Adverse effect of anticoagulants, sequela
  • T45.516A Underdosing of anticoagulants, initial encounter
  • T45.516D Underdosing of anticoagulants, subsequent encounter
  • T45.516S Underdosing of anticoagulants, sequela
  • T45.525A Adverse effect of antithrombotic drugs, initial encounter
  • T45.525D Adverse effect of antithrombotic drugs, subsequent encounter
  • T45.525S Adverse effect of antithrombotic drugs, sequela
  • T45.526A Underdosing of antithrombotic drugs, initial encounter
  • T45.526D Underdosing of antithrombotic drugs, subsequent encounter
  • T45.526S Underdosing of antithrombotic drugs, sequela
  • T45.605A Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
  • T45.605D Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
  • T45.605S Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
  • T45.606A Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter
  • T45.606D Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter
  • T45.606S Underdosing of unspecified fibrinolysis-affecting drugs, sequela
  • T45.615A Adverse effect of thrombolytic drugs, initial encounter
  • T45.615D Adverse effect of thrombolytic drugs, subsequent encounter
  • T45.615S Adverse effect of thrombolytic drugs, sequela
  • T45.616A Underdosing of thrombolytic drugs, initial encounter
  • T45.616D Underdosing of thrombolytic drugs, subsequent encounter
  • T45.616S Underdosing of thrombolytic drugs, sequela
  • T45.625A Adverse effect of hemostatic drug, initial encounter
  • T45.625D Adverse effect of hemostatic drug, subsequent encounter
  • T45.625S Adverse effect of hemostatic drug, sequela
  • T45.626A Underdosing of hemostatic drugs, initial encounter
  • T45.626D Underdosing of hemostatic drugs, subsequent encounter
  • T45.626S Underdosing of hemostatic drugs, sequela
  • T45.695A Adverse effect of other fibrinolysis-affecting drugs, initial encounter
  • T45.695D Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
  • T45.695S Adverse effect of other fibrinolysis-affecting drugs, sequela
  • T45.696A Underdosing of other fibrinolysis-affecting drugs, initial encounter
  • T45.696D Underdosing of other fibrinolysis-affecting drugs, subsequent encounter
  • T45.696S Underdosing of other fibrinolysis-affecting drugs, sequela
  • T45.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
  • T45.7X5D Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
  • T45.7X5S Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
  • T45.7X6A Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter
  • T45.7X6D Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter
  • T45.7X6S Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela
  • T45.8X5A Adverse effect of other primarily systemic and hematological agents, initial encounter
  • T45.8X5D Adverse effect of other primarily systemic and hematological agents, subsequent encounter
  • T45.8X5S Adverse effect of other primarily systemic and hematological agents, sequela
  • T45.8X6A Underdosing of other primarily systemic and hematological agents, initial encounter
  • T45.8X6D Underdosing of other primarily systemic and hematological agents, subsequent encounter
  • T45.8X6S Underdosing of other primarily systemic and hematological agents, sequela
  • T45.95XA Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
  • T45.95XD Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
  • T45.95XS Adverse effect of unspecified primarily systemic and hematological agent, sequela
  • T45.96XA Underdosing of unspecified primarily systemic and hematological agent, initial encounter
  • T45.96XD Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter
  • T45.96XS Underdosing of unspecified primarily systemic and hematological agent, sequela
T46 Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system66 codes
  • T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
  • T46.0X5D Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
  • T46.0X5S Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
  • T46.0X6A Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
  • T46.0X6D Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
  • T46.0X6S Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
  • T46.1X5A Adverse effect of calcium-channel blockers, initial encounter
  • T46.1X5D Adverse effect of calcium-channel blockers, subsequent encounter
  • T46.1X5S Adverse effect of calcium-channel blockers, sequela
  • T46.1X6A Underdosing of calcium-channel blockers, initial encounter
  • T46.1X6D Underdosing of calcium-channel blockers, subsequent encounter
  • T46.1X6S Underdosing of calcium-channel blockers, sequela
  • T46.2X5A Adverse effect of other antidysrhythmic drugs, initial encounter
  • T46.2X5D Adverse effect of other antidysrhythmic drugs, subsequent encounter
  • T46.2X5S Adverse effect of other antidysrhythmic drugs, sequela
  • T46.2X6A Underdosing of other antidysrhythmic drugs, initial encounter
  • T46.2X6D Underdosing of other antidysrhythmic drugs, subsequent encounter
  • T46.2X6S Underdosing of other antidysrhythmic drugs, sequela
  • T46.3X5A Adverse effect of coronary vasodilators, initial encounter
  • T46.3X5D Adverse effect of coronary vasodilators, subsequent encounter
  • T46.3X5S Adverse effect of coronary vasodilators, sequela
  • T46.3X6A Underdosing of coronary vasodilators, initial encounter
  • T46.3X6D Underdosing of coronary vasodilators, subsequent encounter
  • T46.3X6S Underdosing of coronary vasodilators, sequela
  • T46.4X5A Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
  • T46.4X5D Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
  • T46.4X5S Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
  • T46.4X6A Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter
  • T46.4X6D Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
  • T46.4X6S Underdosing of angiotensin-converting-enzyme inhibitors, sequela
  • T46.5X5A Adverse effect of other antihypertensive drugs, initial encounter
  • T46.5X5D Adverse effect of other antihypertensive drugs, subsequent encounter
  • T46.5X5S Adverse effect of other antihypertensive drugs, sequela
  • T46.5X6A Underdosing of other antihypertensive drugs, initial encounter
  • T46.5X6D Underdosing of other antihypertensive drugs, subsequent encounter
  • T46.5X6S Underdosing of other antihypertensive drugs, sequela
  • T46.6X5A Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
  • T46.6X5D Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
  • T46.6X5S Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
  • T46.6X6A Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
  • T46.6X6D Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
  • T46.6X6S Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
  • T46.7X5A Adverse effect of peripheral vasodilators, initial encounter
  • T46.7X5D Adverse effect of peripheral vasodilators, subsequent encounter
  • T46.7X5S Adverse effect of peripheral vasodilators, sequela
  • T46.7X6A Underdosing of peripheral vasodilators, initial encounter
  • T46.7X6D Underdosing of peripheral vasodilators, subsequent encounter
  • T46.7X6S Underdosing of peripheral vasodilators, sequela
  • T46.8X5A Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
  • T46.8X5D Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
  • T46.8X5S Adverse effect of antivaricose drugs, including sclerosing agents, sequela
  • T46.8X6A Underdosing of antivaricose drugs, including sclerosing agents, initial encounter
  • T46.8X6D Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
  • T46.8X6S Underdosing of antivaricose drugs, including sclerosing agents, sequela
  • T46.905A Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
  • T46.905D Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
  • T46.905S Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
  • T46.906A Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
  • T46.906D Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
  • T46.906S Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
  • T46.995A Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
  • T46.995D Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
  • T46.995S Adverse effect of other agents primarily affecting the cardiovascular system, sequela
  • T46.996A Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
  • T46.996D Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
  • T46.996S Underdosing of other agents primarily affecting the cardiovascular system, sequela
T47 Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system60 codes
  • T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter
  • T47.0X5D Adverse effect of histamine H2-receptor blockers, subsequent encounter
  • T47.0X5S Adverse effect of histamine H2-receptor blockers, sequela
  • T47.0X6A Underdosing of histamine H2-receptor blockers, initial encounter
  • T47.0X6D Underdosing of histamine H2-receptor blockers, subsequent encounter
  • T47.0X6S Underdosing of histamine H2-receptor blockers, sequela
  • T47.1X5A Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
  • T47.1X5D Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
  • T47.1X5S Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
  • T47.1X6A Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter
  • T47.1X6D Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter
  • T47.1X6S Underdosing of other antacids and anti-gastric-secretion drugs, sequela
  • T47.2X5A Adverse effect of stimulant laxatives, initial encounter
  • T47.2X5D Adverse effect of stimulant laxatives, subsequent encounter
  • T47.2X5S Adverse effect of stimulant laxatives, sequela
  • T47.2X6A Underdosing of stimulant laxatives, initial encounter
  • T47.2X6D Underdosing of stimulant laxatives, subsequent encounter
  • T47.2X6S Underdosing of stimulant laxatives, sequela
  • T47.3X5A Adverse effect of saline and osmotic laxatives, initial encounter
  • T47.3X5D Adverse effect of saline and osmotic laxatives, subsequent encounter
  • T47.3X5S Adverse effect of saline and osmotic laxatives, sequela
  • T47.3X6A Underdosing of saline and osmotic laxatives, initial encounter
  • T47.3X6D Underdosing of saline and osmotic laxatives, subsequent encounter
  • T47.3X6S Underdosing of saline and osmotic laxatives, sequela
  • T47.4X5A Adverse effect of other laxatives, initial encounter
  • T47.4X5D Adverse effect of other laxatives, subsequent encounter
  • T47.4X5S Adverse effect of other laxatives, sequela
  • T47.4X6A Underdosing of other laxatives, initial encounter
  • T47.4X6D Underdosing of other laxatives, subsequent encounter
  • T47.4X6S Underdosing of other laxatives, sequela
  • T47.5X5A Adverse effect of digestants, initial encounter
  • T47.5X5D Adverse effect of digestants, subsequent encounter
  • T47.5X5S Adverse effect of digestants, sequela
  • T47.5X6A Underdosing of digestants, initial encounter
  • T47.5X6D Underdosing of digestants, subsequent encounter
  • T47.5X6S Underdosing of digestants, sequela
  • T47.6X5A Adverse effect of antidiarrheal drugs, initial encounter
  • T47.6X5D Adverse effect of antidiarrheal drugs, subsequent encounter
  • T47.6X5S Adverse effect of antidiarrheal drugs, sequela
  • T47.6X6A Underdosing of antidiarrheal drugs, initial encounter
  • T47.6X6D Underdosing of antidiarrheal drugs, subsequent encounter
  • T47.6X6S Underdosing of antidiarrheal drugs, sequela
  • T47.7X5A Adverse effect of emetics, initial encounter
  • T47.7X5D Adverse effect of emetics, subsequent encounter
  • T47.7X5S Adverse effect of emetics, sequela
  • T47.7X6A Underdosing of emetics, initial encounter
  • T47.7X6D Underdosing of emetics, subsequent encounter
  • T47.7X6S Underdosing of emetics, sequela
  • T47.8X5A Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
  • T47.8X5D Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
  • T47.8X5S Adverse effect of other agents primarily affecting gastrointestinal system, sequela
  • T47.8X6A Underdosing of other agents primarily affecting gastrointestinal system, initial encounter
  • T47.8X6D Underdosing of other agents primarily affecting gastrointestinal system, subsequent encounter
  • T47.8X6S Underdosing of other agents primarily affecting gastrointestinal system, sequela
  • T47.95XA Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
  • T47.95XD Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
  • T47.95XS Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
  • T47.96XA Underdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter
  • T47.96XD Underdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
  • T47.96XS Underdosing of unspecified agents primarily affecting the gastrointestinal system, sequela
T48 Poisoning by, adverse effect of and underdosing of agents primarily acting on smooth and skeletal muscles and the respiratory system60 codes
  • T48.0X5A Adverse effect of oxytocic drugs, initial encounter
  • T48.0X5D Adverse effect of oxytocic drugs, subsequent encounter
  • T48.0X5S Adverse effect of oxytocic drugs, sequela
  • T48.0X6A Underdosing of oxytocic drugs, initial encounter
  • T48.0X6D Underdosing of oxytocic drugs, subsequent encounter
  • T48.0X6S Underdosing of oxytocic drugs, sequela
  • T48.1X5A Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
  • T48.1X5D Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
  • T48.1X5S Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
  • T48.1X6A Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
  • T48.1X6D Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
  • T48.1X6S Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela
  • T48.205A Adverse effect of unspecified drugs acting on muscles, initial encounter
  • T48.205D Adverse effect of unspecified drugs acting on muscles, subsequent encounter
  • T48.205S Adverse effect of unspecified drugs acting on muscles, sequela
  • T48.206A Underdosing of unspecified drugs acting on muscles, initial encounter
  • T48.206D Underdosing of unspecified drugs acting on muscles, subsequent encounter
  • T48.206S Underdosing of unspecified drugs acting on muscles, sequela
  • T48.295A Adverse effect of other drugs acting on muscles, initial encounter
  • T48.295D Adverse effect of other drugs acting on muscles, subsequent encounter
  • T48.295S Adverse effect of other drugs acting on muscles, sequela
  • T48.296A Underdosing of other drugs acting on muscles, initial encounter
  • T48.296D Underdosing of other drugs acting on muscles, subsequent encounter
  • T48.296S Underdosing of other drugs acting on muscles, sequela
  • T48.3X5A Adverse effect of antitussives, initial encounter
  • T48.3X5D Adverse effect of antitussives, subsequent encounter
  • T48.3X5S Adverse effect of antitussives, sequela
  • T48.3X6A Underdosing of antitussives, initial encounter
  • T48.3X6D Underdosing of antitussives, subsequent encounter
  • T48.3X6S Underdosing of antitussives, sequela
  • T48.4X5A Adverse effect of expectorants, initial encounter
  • T48.4X5D Adverse effect of expectorants, subsequent encounter
  • T48.4X5S Adverse effect of expectorants, sequela
  • T48.4X6A Underdosing of expectorants, initial encounter
  • T48.4X6D Underdosing of expectorants, subsequent encounter
  • T48.4X6S Underdosing of expectorants, sequela
  • T48.5X5A Adverse effect of other anti-common-cold drugs, initial encounter
  • T48.5X5D Adverse effect of other anti-common-cold drugs, subsequent encounter
  • T48.5X5S Adverse effect of other anti-common-cold drugs, sequela
  • T48.5X6A Underdosing of other anti-common-cold drugs, initial encounter
  • T48.5X6D Underdosing of other anti-common-cold drugs, subsequent encounter
  • T48.5X6S Underdosing of other anti-common-cold drugs, sequela
  • T48.6X5A Adverse effect of antiasthmatics, initial encounter
  • T48.6X5D Adverse effect of antiasthmatics, subsequent encounter
  • T48.6X5S Adverse effect of antiasthmatics, sequela
  • T48.6X6A Underdosing of antiasthmatics, initial encounter
  • T48.6X6D Underdosing of antiasthmatics, subsequent encounter
  • T48.6X6S Underdosing of antiasthmatics, sequela
  • T48.905A Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
  • T48.905D Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
  • T48.905S Adverse effect of unspecified agents primarily acting on the respiratory system, sequela
  • T48.906A Underdosing of unspecified agents primarily acting on the respiratory system, initial encounter
  • T48.906D Underdosing of unspecified agents primarily acting on the respiratory system, subsequent encounter
  • T48.906S Underdosing of unspecified agents primarily acting on the respiratory system, sequela
  • T48.995A Adverse effect of other agents primarily acting on the respiratory system, initial encounter
  • T48.995D Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter
  • T48.995S Adverse effect of other agents primarily acting on the respiratory system, sequela
  • T48.996A Underdosing of other agents primarily acting on the respiratory system, initial encounter
  • T48.996D Underdosing of other agents primarily acting on the respiratory system, subsequent encounter
  • T48.996S Underdosing of other agents primarily acting on the respiratory system, sequela
T49 Poisoning by, adverse effect of and underdosing of topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinorlaryngological and dental drugs60 codes
  • T49.0X5A Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
  • T49.0X5D Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
  • T49.0X5S Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
  • T49.0X6A Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
  • T49.0X6D Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
  • T49.0X6S Underdosing of local antifungal, anti-infective and anti-inflammatory drugs, sequela
  • T49.1X5A Adverse effect of antipruritics, initial encounter
  • T49.1X5D Adverse effect of antipruritics, subsequent encounter
  • T49.1X5S Adverse effect of antipruritics, sequela
  • T49.1X6A Underdosing of antipruritics, initial encounter
  • T49.1X6D Underdosing of antipruritics, subsequent encounter
  • T49.1X6S Underdosing of antipruritics, sequela
  • T49.2X5A Adverse effect of local astringents and local detergents, initial encounter
  • T49.2X5D Adverse effect of local astringents and local detergents, subsequent encounter
  • T49.2X5S Adverse effect of local astringents and local detergents, sequela
  • T49.2X6A Underdosing of local astringents and local detergents, initial encounter
  • T49.2X6D Underdosing of local astringents and local detergents, subsequent encounter
  • T49.2X6S Underdosing of local astringents and local detergents, sequela
  • T49.3X5A Adverse effect of emollients, demulcents and protectants, initial encounter
  • T49.3X5D Adverse effect of emollients, demulcents and protectants, subsequent encounter
  • T49.3X5S Adverse effect of emollients, demulcents and protectants, sequela
  • T49.3X6A Underdosing of emollients, demulcents and protectants, initial encounter
  • T49.3X6D Underdosing of emollients, demulcents and protectants, subsequent encounter
  • T49.3X6S Underdosing of emollients, demulcents and protectants, sequela
  • T49.4X5A Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
  • T49.4X5D Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
  • T49.4X5S Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
  • T49.4X6A Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
  • T49.4X6D Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
  • T49.4X6S Underdosing of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
  • T49.5X5A Adverse effect of ophthalmological drugs and preparations, initial encounter
  • T49.5X5D Adverse effect of ophthalmological drugs and preparations, subsequent encounter
  • T49.5X5S Adverse effect of ophthalmological drugs and preparations, sequela
  • T49.5X6A Underdosing of ophthalmological drugs and preparations, initial encounter
  • T49.5X6D Underdosing of ophthalmological drugs and preparations, subsequent encounter
  • T49.5X6S Underdosing of ophthalmological drugs and preparations, sequela
  • T49.6X5A Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
  • T49.6X5D Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
  • T49.6X5S Adverse effect of otorhinolaryngological drugs and preparations, sequela
  • T49.6X6A Underdosing of otorhinolaryngological drugs and preparations, initial encounter
  • T49.6X6D Underdosing of otorhinolaryngological drugs and preparations, subsequent encounter
  • T49.6X6S Underdosing of otorhinolaryngological drugs and preparations, sequela
  • T49.7X5A Adverse effect of dental drugs, topically applied, initial encounter
  • T49.7X5D Adverse effect of dental drugs, topically applied, subsequent encounter
  • T49.7X5S Adverse effect of dental drugs, topically applied, sequela
  • T49.7X6A Underdosing of dental drugs, topically applied, initial encounter
  • T49.7X6D Underdosing of dental drugs, topically applied, subsequent encounter
  • T49.7X6S Underdosing of dental drugs, topically applied, sequela
  • T49.8X5A Adverse effect of other topical agents, initial encounter
  • T49.8X5D Adverse effect of other topical agents, subsequent encounter
  • T49.8X5S Adverse effect of other topical agents, sequela
  • T49.8X6A Underdosing of other topical agents, initial encounter
  • T49.8X6D Underdosing of other topical agents, subsequent encounter
  • T49.8X6S Underdosing of other topical agents, sequela
  • T49.95XA Adverse effect of unspecified topical agent, initial encounter
  • T49.95XD Adverse effect of unspecified topical agent, subsequent encounter
  • T49.95XS Adverse effect of unspecified topical agent, sequela
  • T49.96XA Underdosing of unspecified topical agent, initial encounter
  • T49.96XD Underdosing of unspecified topical agent, subsequent encounter
  • T49.96XS Underdosing of unspecified topical agent, sequela
T50 Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances102 codes
  • T50.0X5A Adverse effect of mineralocorticoids and their antagonists, initial encounter
  • T50.0X5D Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
  • T50.0X5S Adverse effect of mineralocorticoids and their antagonists, sequela
  • T50.0X6A Underdosing of mineralocorticoids and their antagonists, initial encounter
  • T50.0X6D Underdosing of mineralocorticoids and their antagonists, subsequent encounter
  • T50.0X6S Underdosing of mineralocorticoids and their antagonists, sequela
  • T50.1X5A Adverse effect of loop [high-ceiling] diuretics, initial encounter
  • T50.1X5D Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
  • T50.1X5S Adverse effect of loop [high-ceiling] diuretics, sequela
  • T50.1X6A Underdosing of loop [high-ceiling] diuretics, initial encounter
  • T50.1X6D Underdosing of loop [high-ceiling] diuretics, subsequent encounter
  • T50.1X6S Underdosing of loop [high-ceiling] diuretics, sequela
  • T50.2X5A Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
  • T50.2X5D Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
  • T50.2X5S Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
  • T50.2X6A Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
  • T50.2X6D Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
  • T50.2X6S Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
  • T50.3X5A Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
  • T50.3X5D Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
  • T50.3X5S Adverse effect of electrolytic, caloric and water-balance agents, sequela
  • T50.3X6A Underdosing of electrolytic, caloric and water-balance agents, initial encounter
  • T50.3X6D Underdosing of electrolytic, caloric and water-balance agents, subsequent encounter
  • T50.3X6S Underdosing of electrolytic, caloric and water-balance agents, sequela
  • T50.4X5A Adverse effect of drugs affecting uric acid metabolism, initial encounter
  • T50.4X5D Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
  • T50.4X5S Adverse effect of drugs affecting uric acid metabolism, sequela
  • T50.4X6A Underdosing of drugs affecting uric acid metabolism, initial encounter
  • T50.4X6D Underdosing of drugs affecting uric acid metabolism, subsequent encounter
  • T50.4X6S Underdosing of drugs affecting uric acid metabolism, sequela
  • T50.5X5A Adverse effect of appetite depressants, initial encounter
  • T50.5X5D Adverse effect of appetite depressants, subsequent encounter
  • T50.5X5S Adverse effect of appetite depressants, sequela
  • T50.5X6A Underdosing of appetite depressants, initial encounter
  • T50.5X6D Underdosing of appetite depressants, subsequent encounter
  • T50.5X6S Underdosing of appetite depressants, sequela
  • T50.6X5A Adverse effect of antidotes and chelating agents, initial encounter
  • T50.6X5D Adverse effect of antidotes and chelating agents, subsequent encounter
  • T50.6X5S Adverse effect of antidotes and chelating agents, sequela
  • T50.6X6A Underdosing of antidotes and chelating agents, initial encounter
  • T50.6X6D Underdosing of antidotes and chelating agents, subsequent encounter
  • T50.6X6S Underdosing of antidotes and chelating agents, sequela
  • T50.7X5A Adverse effect of analeptics and opioid receptor antagonists, initial encounter
  • T50.7X5D Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
  • T50.7X5S Adverse effect of analeptics and opioid receptor antagonists, sequela
  • T50.7X6A Underdosing of analeptics and opioid receptor antagonists, initial encounter
  • T50.7X6D Underdosing of analeptics and opioid receptor antagonists, subsequent encounter
  • T50.7X6S Underdosing of analeptics and opioid receptor antagonists, sequela
  • T50.8X5A Adverse effect of diagnostic agents, initial encounter
  • T50.8X5D Adverse effect of diagnostic agents, subsequent encounter
  • T50.8X5S Adverse effect of diagnostic agents, sequela
  • T50.8X6A Underdosing of diagnostic agents, initial encounter
  • T50.8X6D Underdosing of diagnostic agents, subsequent encounter
  • T50.8X6S Underdosing of diagnostic agents, sequela
  • T50.915A Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
  • T50.915D Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
  • T50.915S Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela
  • T50.916A Underdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter
  • T50.916D Underdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
  • T50.916S Underdosing of multiple unspecified drugs, medicaments and biological substances, sequela
  • T50.A15A Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
  • T50.A15D Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
  • T50.A15S Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
  • T50.A16A Underdosing of pertussis vaccine, including combinations with a pertussis component, initial encounter
  • T50.A16D Underdosing of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
  • T50.A16S Underdosing of pertussis vaccine, including combinations with a pertussis component, sequela
  • T50.A25A Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
  • T50.A25D Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter
  • T50.A25S Adverse effect of mixed bacterial vaccines without a pertussis component, sequela
  • T50.A26A Underdosing of mixed bacterial vaccines without a pertussis component, initial encounter
  • T50.A26D Underdosing of mixed bacterial vaccines without a pertussis component, subsequent encounter
  • T50.A26S Underdosing of mixed bacterial vaccines without a pertussis component, sequela
  • T50.A95A Adverse effect of other bacterial vaccines, initial encounter
  • T50.A95D Adverse effect of other bacterial vaccines, subsequent encounter
  • T50.A95S Adverse effect of other bacterial vaccines, sequela
  • T50.A96A Underdosing of other bacterial vaccines, initial encounter
  • T50.A96D Underdosing of other bacterial vaccines, subsequent encounter
  • T50.A96S Underdosing of other bacterial vaccines, sequela
  • T50.B15A Adverse effect of smallpox vaccines, initial encounter
  • T50.B15D Adverse effect of smallpox vaccines, subsequent encounter
  • T50.B15S Adverse effect of smallpox vaccines, sequela
  • T50.B16A Underdosing of smallpox vaccines, initial encounter
  • T50.B16D Underdosing of smallpox vaccines, subsequent encounter
  • T50.B16S Underdosing of smallpox vaccines, sequela
  • T50.B95A Adverse effect of other viral vaccines, initial encounter
  • T50.B95D Adverse effect of other viral vaccines, subsequent encounter
  • T50.B95S Adverse effect of other viral vaccines, sequela
  • T50.B96A Underdosing of other viral vaccines, initial encounter
  • T50.B96D Underdosing of other viral vaccines, subsequent encounter
  • T50.B96S Underdosing of other viral vaccines, sequela
  • T50.Z15A Adverse effect of immunoglobulin, initial encounter
  • T50.Z15D Adverse effect of immunoglobulin, subsequent encounter
  • T50.Z15S Adverse effect of immunoglobulin, sequela
  • T50.Z16A Underdosing of immunoglobulin, initial encounter
  • T50.Z16D Underdosing of immunoglobulin, subsequent encounter
  • T50.Z16S Underdosing of immunoglobulin, sequela
  • T50.Z95A Adverse effect of other vaccines and biological substances, initial encounter
  • T50.Z95D Adverse effect of other vaccines and biological substances, subsequent encounter
  • T50.Z95S Adverse effect of other vaccines and biological substances, sequela
  • T50.Z96A Underdosing of other vaccines and biological substances, initial encounter
  • T50.Z96D Underdosing of other vaccines and biological substances, subsequent encounter
  • T50.Z96S Underdosing of other vaccines and biological substances, sequela
T78 Adverse effects, not elsewhere classified21 codes
  • T78.110A Other adverse food reactions due to milk and dairy products with tolerance to baked milk, initial encounter
  • T78.110D Other adverse food reactions due to milk and dairy products with tolerance to baked milk, subsequent encounter
  • T78.110S Other adverse food reactions due to milk and dairy products with tolerance to baked milk, sequela
  • T78.111A Other adverse food reaction due to milk and dairy products with reactivity to baked milk, initial encounter
  • T78.111D Other adverse food reaction due to milk and dairy products with reactivity to baked milk, subsequent encounter
  • T78.111S Other adverse food reaction due to milk and dairy products with reactivity to baked milk, sequela
  • T78.119A Other adverse food reaction due to milk and dairy products with baked milk tolerance/reactivity, unspecified, initial encounter
  • T78.119D Other adverse food reaction due to milk and dairy products with baked milk tolerance/reactivity, unspecified, subsequent encounter
  • T78.119S Other adverse food reaction due to milk and dairy products with baked milk tolerance/reactivity, unspecified, sequela
  • T78.120A Other adverse food reaction due to egg with tolerance to baked egg, initial encounter
  • T78.120D Other adverse food reaction due to egg with tolerance to baked egg, subsequent encounter
  • T78.120S Other adverse food reaction due to egg with tolerance to baked egg, sequela
  • T78.121A Other adverse food reaction due to egg with reactivity to baked egg, initial encounter
  • T78.121D Other adverse food reaction due to egg with reactivity to baked egg, subsequent encounter
  • T78.121S Other adverse food reaction due to egg with reactivity to baked egg, sequela
  • T78.129A Other adverse food reaction due to egg with baked egg tolerance/reactivity, unspecified, initial encounter
  • T78.129D Other adverse food reaction due to egg with baked egg tolerance/reactivity, unspecified, subsequent encounter
  • T78.129S Other adverse food reaction due to egg with baked egg tolerance/reactivity, unspecified, sequela
  • T78.19XA Other adverse food reactions, not elsewhere classified, initial encounter
  • T78.19XD Other adverse food reactions, not elsewhere classified, subsequent encounter
  • T78.19XS Other adverse food reactions, not elsewhere classified, sequela
T81 Complications of procedures, not elsewhere classified3 codes
  • T81.12XA Postprocedural septic shock, initial encounter
  • T81.12XD Postprocedural septic shock, subsequent encounter
  • T81.12XS Postprocedural septic shock, sequela
Z00 Encounter for general examination without complaint, suspected or reported diagnosis12 codes
  • Z00.00 Encounter for general adult medical examination without abnormal findings
  • Z00.01 Encounter for general adult medical examination with abnormal findings
  • Z00.110 Health examination for newborn under 8 days old
  • Z00.111 Health examination for newborn 8 to 28 days old
  • Z00.121 Encounter for routine child health examination with abnormal findings
  • Z00.129 Encounter for routine child health examination without abnormal findings
  • Z00.2 Encounter for examination for period of rapid growth in childhood
  • Z00.3 Encounter for examination for adolescent development state
  • Z00.5 Encounter for examination of potential donor of organ and tissue
  • Z00.70 Encounter for examination for period of delayed growth in childhood without abnormal findings
  • Z00.71 Encounter for examination for period of delayed growth in childhood with abnormal findings
  • Z00.8 Encounter for other general examination
Z01 Encounter for other special examination without complaint, suspected or reported diagnosis14 codes
  • Z01.10 Encounter for examination of ears and hearing without abnormal findings
  • Z01.110 Encounter for hearing examination following failed hearing screening
  • Z01.118 Encounter for examination of ears and hearing with other abnormal findings
  • Z01.12 Encounter for hearing conservation and treatment
  • Z01.20 Encounter for dental examination and cleaning without abnormal findings
  • Z01.21 Encounter for dental examination and cleaning with abnormal findings
  • Z01.30 Encounter for examination of blood pressure without abnormal findings
  • Z01.31 Encounter for examination of blood pressure with abnormal findings
  • Z01.812 Encounter for preprocedural laboratory examination
  • Z01.818 Encounter for other preprocedural examination
  • Z01.82 Encounter for allergy testing
  • Z01.83 Encounter for blood typing
  • Z01.84 Encounter for antibody response examination
  • Z01.89 Encounter for other specified special examinations
Z02 Encounter for administrative examination11 codes
  • Z02.0 Encounter for examination for admission to educational institution
  • Z02.2 Encounter for examination for admission to residential institution
  • Z02.4 Encounter for examination for driving license
  • Z02.5 Encounter for examination for participation in sport
  • Z02.6 Encounter for examination for insurance purposes
  • Z02.71 Encounter for disability determination
  • Z02.79 Encounter for issue of other medical certificate
  • Z02.82 Encounter for adoption services
  • Z02.84 Encounter for child welfare exam
  • Z02.89 Encounter for other administrative examinations
  • Z02.9 Encounter for administrative examinations, unspecified
Z03 Encounter for medical observation for suspected diseases and conditions ruled out10 codes
  • Z03.71 Encounter for suspected problem with amniotic cavity and membrane ruled out
  • Z03.72 Encounter for suspected placental problem ruled out
  • Z03.73 Encounter for suspected fetal anomaly ruled out
  • Z03.74 Encounter for suspected problem with fetal growth ruled out
  • Z03.75 Encounter for suspected cervical shortening ruled out
  • Z03.79 Encounter for other suspected maternal and fetal conditions ruled out
  • Z03.821 Encounter for observation for suspected ingested foreign body ruled out
  • Z03.822 Encounter for observation for suspected aspirated (inhaled) foreign body ruled out
  • Z03.823 Encounter for observation for suspected inserted (injected) foreign body ruled out
  • Z03.83 Encounter for observation for suspected conditions related to home physiologic monitoring device ruled out
Z04 Encounter for examination and observation for other reasons1 code
  • Z04.9 Encounter for examination and observation for unspecified reason
Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm1 code
  • Z08 Encounter for follow-up examination after completed treatment for malignant neoplasm
Z09 Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm1 code
  • Z09 Encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm
Z11 Encounter for screening for infectious and parasitic diseases12 codes
  • Z11.0 Encounter for screening for intestinal infectious diseases
  • Z11.1 Encounter for screening for respiratory tuberculosis
  • Z11.2 Encounter for screening for other bacterial diseases
  • Z11.3 Encounter for screening for infections with a predominantly sexual mode of transmission
  • Z11.4 Encounter for screening for human immunodeficiency virus [HIV]
  • Z11.51 Encounter for screening for human papillomavirus (HPV)
  • Z11.52 Encounter for screening for COVID-19
  • Z11.59 Encounter for screening for other viral diseases
  • Z11.6 Encounter for screening for other protozoal diseases and helminthiases
  • Z11.7 Encounter for testing for latent tuberculosis infection
  • Z11.8 Encounter for screening for other infectious and parasitic diseases
  • Z11.9 Encounter for screening for infectious and parasitic diseases, unspecified
Z12 Encounter for screening for malignant neoplasms19 codes
  • Z12.0 Encounter for screening for malignant neoplasm of stomach
  • Z12.10 Encounter for screening for malignant neoplasm of intestinal tract, unspecified
  • Z12.11 Encounter for screening for malignant neoplasm of colon
  • Z12.12 Encounter for screening for malignant neoplasm of rectum
  • Z12.13 Encounter for screening for malignant neoplasm of small intestine
  • Z12.2 Encounter for screening for malignant neoplasm of respiratory organs
  • Z12.31 Encounter for screening mammogram for malignant neoplasm of breast
  • Z12.39 Encounter for other screening for malignant neoplasm of breast
  • Z12.4 Encounter for screening for malignant neoplasm of cervix
  • Z12.6 Encounter for screening for malignant neoplasm of bladder
  • Z12.71 Encounter for screening for malignant neoplasm of testis
  • Z12.72 Encounter for screening for malignant neoplasm of vagina
  • Z12.73 Encounter for screening for malignant neoplasm of ovary
  • Z12.79 Encounter for screening for malignant neoplasm of other genitourinary organs
  • Z12.81 Encounter for screening for malignant neoplasm of oral cavity
  • Z12.82 Encounter for screening for malignant neoplasm of nervous system
  • Z12.83 Encounter for screening for malignant neoplasm of skin
  • Z12.89 Encounter for screening for malignant neoplasm of other sites
  • Z12.9 Encounter for screening for malignant neoplasm, site unspecified
Z13 Encounter for screening for other diseases and disorders30 codes
  • Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
  • Z13.1 Encounter for screening for diabetes mellitus
  • Z13.21 Encounter for screening for nutritional disorder
  • Z13.220 Encounter for screening for lipoid disorders
  • Z13.228 Encounter for screening for other metabolic disorders
  • Z13.29 Encounter for screening for other suspected endocrine disorder
  • Z13.30 Encounter for screening examination for mental health and behavioral disorders, unspecified
  • Z13.31 Encounter for screening for depression
  • Z13.32 Encounter for screening for maternal depression
  • Z13.39 Encounter for screening examination for other mental health and behavioral disorders
  • Z13.40 Encounter for screening for unspecified developmental delays
  • Z13.41 Encounter for autism screening
  • Z13.42 Encounter for screening for global developmental delays (milestones)
  • Z13.49 Encounter for screening for other developmental delays
  • Z13.5 Encounter for screening for eye and ear disorders
  • Z13.6 Encounter for screening for cardiovascular disorders
  • Z13.71 Encounter for nonprocreative screening for genetic disease carrier status
  • Z13.79 Encounter for other screening for genetic and chromosomal anomalies
  • Z13.810 Encounter for screening for upper gastrointestinal disorder
  • Z13.811 Encounter for screening for lower gastrointestinal disorder
  • Z13.818 Encounter for screening for other digestive system disorders
  • Z13.820 Encounter for screening for osteoporosis
  • Z13.828 Encounter for screening for other musculoskeletal disorder
  • Z13.83 Encounter for screening for respiratory disorder NEC
  • Z13.84 Encounter for screening for dental disorders
  • Z13.850 Encounter for screening for traumatic brain injury
  • Z13.858 Encounter for screening for other nervous system disorders
  • Z13.88 Encounter for screening for disorder due to exposure to contaminants
  • Z13.89 Encounter for screening for other disorder
  • Z13.9 Encounter for screening, unspecified
Z14 Genetic carrier4 codes
  • Z14.01 Asymptomatic hemophilia A carrier
  • Z14.02 Symptomatic hemophilia A carrier
  • Z14.1 Cystic fibrosis carrier
  • Z14.8 Genetic carrier of other disease
Z15 Genetic susceptibility to disease14 codes
  • Z15.01 Genetic susceptibility to malignant neoplasm of breast
  • Z15.02 Genetic susceptibility to malignant neoplasm of ovary
  • Z15.03 Genetic susceptibility to malignant neoplasm of prostate
  • Z15.04 Genetic susceptibility to malignant neoplasm of endometrium
  • Z15.05 Genetic susceptibility to malignant neoplasm of fallopian tube(s)
  • Z15.060 Genetic susceptibility to colorectal cancer
  • Z15.068 Genetic susceptibility to other malignant neoplasm of digestive system
  • Z15.07 Genetic susceptibility to malignant neoplasm of urinary tract
  • Z15.09 Genetic susceptibility to other malignant neoplasm
  • Z15.1 Genetic susceptibility to epilepsy and neurodevelopmental disorders
  • Z15.2 Genetic susceptibility to obesity
  • Z15.3 Genetic susceptibility to kidney disease
  • Z15.81 Genetic susceptibility to multiple endocrine neoplasia [MEN]
  • Z15.89 Genetic susceptibility to other disease
Z16 Resistance to antimicrobial drugs19 codes
  • Z16.10 Resistance to unspecified beta lactam antibiotics
  • Z16.11 Resistance to penicillins
  • Z16.12 Extended spectrum beta lactamase (ESBL) resistance
  • Z16.13 Resistance to carbapenem
  • Z16.19 Resistance to other specified beta lactam antibiotics
  • Z16.20 Resistance to unspecified antibiotic
  • Z16.21 Resistance to vancomycin
  • Z16.22 Resistance to vancomycin related antibiotics
  • Z16.23 Resistance to quinolones and fluoroquinolones
  • Z16.24 Resistance to multiple antibiotics
  • Z16.29 Resistance to other single specified antibiotic
  • Z16.30 Resistance to unspecified antimicrobial drugs
  • Z16.31 Resistance to antiparasitic drug(s)
  • Z16.32 Resistance to antifungal drug(s)
  • Z16.33 Resistance to antiviral drug(s)
  • Z16.341 Resistance to single antimycobacterial drug
  • Z16.342 Resistance to multiple antimycobacterial drugs
  • Z16.35 Resistance to multiple antimicrobial drugs
  • Z16.39 Resistance to other specified antimicrobial drug
Z17 Estrogen, and other hormones and factors receptor status10 codes
  • Z17.0 Estrogen receptor positive status [ER+]
  • Z17.1 Estrogen receptor negative status [ER-]
  • Z17.21 Progesterone receptor positive status
  • Z17.22 Progesterone receptor negative status
  • Z17.31 Human epidermal growth factor receptor 2 positive status
  • Z17.32 Human epidermal growth factor receptor 2 negative status
  • Z17.410 Hormone receptor positive with human epidermal growth factor receptor 2 positive status
  • Z17.411 Hormone receptor positive with human epidermal growth factor receptor 2 negative status
  • Z17.420 Hormone receptor negative with human epidermal growth factor receptor 2 positive status
  • Z17.421 Hormone receptor negative with human epidermal growth factor receptor 2 negative status
Z18 Retained foreign body fragments14 codes
  • Z18.01 Retained depleted uranium fragments
  • Z18.09 Other retained radioactive fragments
  • Z18.10 Retained metal fragments, unspecified
  • Z18.11 Retained magnetic metal fragments
  • Z18.12 Retained nonmagnetic metal fragments
  • Z18.2 Retained plastic fragments
  • Z18.31 Retained animal quills or spines
  • Z18.32 Retained tooth
  • Z18.33 Retained wood fragments
  • Z18.39 Other retained organic fragments
  • Z18.81 Retained glass fragments
  • Z18.83 Retained stone or crystalline fragments
  • Z18.89 Other specified retained foreign body fragments
  • Z18.9 Retained foreign body fragments, unspecified material
Z19 Hormone sensitivity malignancy status2 codes
  • Z19.1 Hormone sensitive malignancy status
  • Z19.2 Hormone resistant malignancy status
Z20 Contact with and (suspected) exposure to communicable diseases12 codes
  • Z20.09 Contact with and (suspected) exposure to other intestinal infectious diseases
  • Z20.1 Contact with and (suspected) exposure to tuberculosis
  • Z20.2 Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission
  • Z20.3 Contact with and (suspected) exposure to rabies
  • Z20.4 Contact with and (suspected) exposure to rubella
  • Z20.7 Contact with and (suspected) exposure to pediculosis, acariasis and other infestations
  • Z20.810 Contact with and (suspected) exposure to anthrax
  • Z20.818 Contact with and (suspected) exposure to other bacterial communicable diseases
  • Z20.821 Contact with and (suspected) exposure to Zika virus
  • Z20.822 Contact with and (suspected) exposure to COVID-19
  • Z20.89 Contact with and (suspected) exposure to other communicable diseases
  • Z20.9 Contact with and (suspected) exposure to unspecified communicable disease
Z22 Carrier of infectious disease20 codes
  • Z22.0 Carrier of typhoid
  • Z22.1 Carrier of other intestinal infectious diseases
  • Z22.2 Carrier of diphtheria
  • Z22.31 Carrier of bacterial disease due to meningococci
  • Z22.321 Carrier or suspected carrier of Methicillin susceptible Staphylococcus aureus
  • Z22.322 Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus
  • Z22.330 Carrier of Group B streptococcus
  • Z22.338 Carrier of other streptococcus
  • Z22.340 Carrier of carbapenem-resistant Acinetobacter baumannii
  • Z22.341 Carrier of carbapenem-sensitive Acinetobacter baumannii
  • Z22.349 Carrier of Acinetobacter baumannii, unspecified
  • Z22.350 Carrier of carbapenem-resistant Enterobacterales
  • Z22.358 Carrier of other Enterobacterales
  • Z22.359 Carrier of Enterobacterales, unspecified
  • Z22.39 Carrier of other specified bacterial diseases
  • Z22.4 Carrier of infections with a predominantly sexual mode of transmission
  • Z22.6 Carrier of human T-lymphotropic virus type-1 [HTLV-1] infection
  • Z22.7 Latent tuberculosis
  • Z22.8 Carrier of other infectious diseases
  • Z22.9 Carrier of infectious disease, unspecified
Z23 Encounter for immunization1 code
  • Z23 Encounter for immunization
Z28 Immunization not carried out and underimmunization status17 codes
  • Z28.01 Immunization not carried out because of acute illness of patient
  • Z28.02 Immunization not carried out because of chronic illness or condition of patient
  • Z28.03 Immunization not carried out because of immune compromised state of patient
  • Z28.04 Immunization not carried out because of patient allergy to vaccine or component
  • Z28.09 Immunization not carried out because of other contraindication
  • Z28.1 Immunization not carried out because of patient decision for reasons of belief or group pressure
  • Z28.20 Immunization not carried out because of patient decision for unspecified reason
  • Z28.21 Immunization not carried out because of patient refusal
  • Z28.29 Immunization not carried out because of patient decision for other reason
  • Z28.310 Unvaccinated for COVID-19
  • Z28.311 Partially vaccinated for COVID-19
  • Z28.39 Other underimmunization status
  • Z28.81 Immunization not carried out due to patient having had the disease
  • Z28.82 Immunization not carried out because of caregiver refusal
  • Z28.83 Immunization not carried out due to unavailability of vaccine
  • Z28.89 Immunization not carried out for other reason
  • Z28.9 Immunization not carried out for unspecified reason
Z29 Encounter for other prophylactic measures8 codes
  • Z29.11 Encounter for prophylactic immunotherapy for respiratory syncytial virus (RSV)
  • Z29.12 Encounter for prophylactic antivenin
  • Z29.13 Encounter for prophylactic Rho(D) immune globulin
  • Z29.14 Encounter for prophylactic rabies immune globin
  • Z29.3 Encounter for prophylactic fluoride administration
  • Z29.81 Encounter for HIV pre-exposure prophylaxis
  • Z29.89 Encounter for other specified prophylactic measures
  • Z29.9 Encounter for prophylactic measures, unspecified
Z30 Encounter for contraceptive management24 codes
  • Z30.011 Encounter for initial prescription of contraceptive pills
  • Z30.012 Encounter for prescription of emergency contraception
  • Z30.013 Encounter for initial prescription of injectable contraceptive
  • Z30.014 Encounter for initial prescription of intrauterine contraceptive device
  • Z30.015 Encounter for initial prescription of vaginal ring hormonal contraceptive
  • Z30.016 Encounter for initial prescription of transdermal patch hormonal contraceptive device
  • Z30.017 Encounter for initial prescription of implantable subdermal contraceptive
  • Z30.018 Encounter for initial prescription of other contraceptives
  • Z30.019 Encounter for initial prescription of contraceptives, unspecified
  • Z30.02 Counseling and instruction in natural family planning to avoid pregnancy
  • Z30.09 Encounter for other general counseling and advice on contraception
  • Z30.40 Encounter for surveillance of contraceptives, unspecified
  • Z30.41 Encounter for surveillance of contraceptive pills
  • Z30.42 Encounter for surveillance of injectable contraceptive
  • Z30.430 Encounter for insertion of intrauterine contraceptive device
  • Z30.431 Encounter for routine checking of intrauterine contraceptive device
  • Z30.432 Encounter for removal of intrauterine contraceptive device
  • Z30.433 Encounter for removal and reinsertion of intrauterine contraceptive device
  • Z30.44 Encounter for surveillance of vaginal ring hormonal contraceptive device
  • Z30.45 Encounter for surveillance of transdermal patch hormonal contraceptive device
  • Z30.46 Encounter for surveillance of implantable subdermal contraceptive
  • Z30.49 Encounter for surveillance of other contraceptives
  • Z30.8 Encounter for other contraceptive management
  • Z30.9 Encounter for contraceptive management, unspecified
Z31 Encounter for procreative management19 codes
  • Z31.41 Encounter for fertility testing
  • Z31.42 Aftercare following sterilization reversal
  • Z31.430 Encounter of female for testing for genetic disease carrier status for procreative management
  • Z31.438 Encounter for other genetic testing of female for procreative management
  • Z31.440 Encounter of male for testing for genetic disease carrier status for procreative management
  • Z31.441 Encounter for testing of male partner of patient with recurrent pregnancy loss
  • Z31.448 Encounter for other genetic testing of male for procreative management
  • Z31.49 Encounter for other procreative investigation and testing
  • Z31.5 Encounter for procreative genetic counseling
  • Z31.61 Procreative counseling and advice using natural family planning
  • Z31.62 Encounter for fertility preservation counseling
  • Z31.69 Encounter for other general counseling and advice on procreation
  • Z31.7 Encounter for procreative management and counseling for gestational carrier
  • Z31.81 Encounter for male factor infertility in female patient
  • Z31.82 Encounter for Rh incompatibility status
  • Z31.83 Encounter for assisted reproductive fertility procedure cycle
  • Z31.84 Encounter for fertility preservation procedure
  • Z31.89 Encounter for other procreative management
  • Z31.9 Encounter for procreative management, unspecified
Z32 Encounter for pregnancy test and childbirth and childcare instruction2 codes
  • Z32.2 Encounter for childbirth instruction
  • Z32.3 Encounter for childcare instruction
Z33 Pregnant state2 codes
  • Z33.1 Pregnant state, incidental
  • Z33.3 Pregnant state, gestational carrier
Z34 Encounter for supervision of normal pregnancy12 codes
  • Z34.00 Encounter for supervision of normal first pregnancy, unspecified trimester
  • Z34.01 Encounter for supervision of normal first pregnancy, first trimester
  • Z34.02 Encounter for supervision of normal first pregnancy, second trimester
  • Z34.03 Encounter for supervision of normal first pregnancy, third trimester
  • Z34.80 Encounter for supervision of other normal pregnancy, unspecified trimester
  • Z34.81 Encounter for supervision of other normal pregnancy, first trimester
  • Z34.82 Encounter for supervision of other normal pregnancy, second trimester
  • Z34.83 Encounter for supervision of other normal pregnancy, third trimester
  • Z34.90 Encounter for supervision of normal pregnancy, unspecified, unspecified trimester
  • Z34.91 Encounter for supervision of normal pregnancy, unspecified, first trimester
  • Z34.92 Encounter for supervision of normal pregnancy, unspecified, second trimester
  • Z34.93 Encounter for supervision of normal pregnancy, unspecified, third trimester
Z37 Outcome of delivery19 codes
  • Z37.0 Single live birth
  • Z37.1 Single stillbirth
  • Z37.2 Twins, both liveborn
  • Z37.3 Twins, one liveborn and one stillborn
  • Z37.4 Twins, both stillborn
  • Z37.50 Multiple births, unspecified, all liveborn
  • Z37.51 Triplets, all liveborn
  • Z37.52 Quadruplets, all liveborn
  • Z37.53 Quintuplets, all liveborn
  • Z37.54 Sextuplets, all liveborn
  • Z37.59 Other multiple births, all liveborn
  • Z37.60 Multiple births, unspecified, some liveborn
  • Z37.61 Triplets, some liveborn
  • Z37.62 Quadruplets, some liveborn
  • Z37.63 Quintuplets, some liveborn
  • Z37.64 Sextuplets, some liveborn
  • Z37.69 Other multiple births, some liveborn
  • Z37.7 Other multiple births, all stillborn
  • Z37.9 Outcome of delivery, unspecified
Z39 Encounter for maternal postpartum care and examination2 codes
  • Z39.1 Encounter for care and examination of lactating mother
  • Z39.2 Encounter for routine postpartum follow-up
Z3A Weeks of gestation38 codes
  • Z3A.00 Weeks of gestation of pregnancy not specified
  • Z3A.01 Less than 8 weeks gestation of pregnancy
  • Z3A.08 8 weeks gestation of pregnancy
  • Z3A.09 9 weeks gestation of pregnancy
  • Z3A.10 10 weeks gestation of pregnancy
  • Z3A.11 11 weeks gestation of pregnancy
  • Z3A.12 12 weeks gestation of pregnancy
  • Z3A.13 13 weeks gestation of pregnancy
  • Z3A.14 14 weeks gestation of pregnancy
  • Z3A.15 15 weeks gestation of pregnancy
  • Z3A.16 16 weeks gestation of pregnancy
  • Z3A.17 17 weeks gestation of pregnancy
  • Z3A.18 18 weeks gestation of pregnancy
  • Z3A.19 19 weeks gestation of pregnancy
  • Z3A.20 20 weeks gestation of pregnancy
  • Z3A.21 21 weeks gestation of pregnancy
  • Z3A.22 22 weeks gestation of pregnancy
  • Z3A.23 23 weeks gestation of pregnancy
  • Z3A.24 24 weeks gestation of pregnancy
  • Z3A.25 25 weeks gestation of pregnancy
  • Z3A.26 26 weeks gestation of pregnancy
  • Z3A.27 27 weeks gestation of pregnancy
  • Z3A.28 28 weeks gestation of pregnancy
  • Z3A.29 29 weeks gestation of pregnancy
  • Z3A.30 30 weeks gestation of pregnancy
  • Z3A.31 31 weeks gestation of pregnancy
  • Z3A.32 32 weeks gestation of pregnancy
  • Z3A.33 33 weeks gestation of pregnancy
  • Z3A.34 34 weeks gestation of pregnancy
  • Z3A.35 35 weeks gestation of pregnancy
  • Z3A.36 36 weeks gestation of pregnancy
  • Z3A.37 37 weeks gestation of pregnancy
  • Z3A.38 38 weeks gestation of pregnancy
  • Z3A.39 39 weeks gestation of pregnancy
  • Z3A.40 40 weeks gestation of pregnancy
  • Z3A.41 41 weeks gestation of pregnancy
  • Z3A.42 42 weeks gestation of pregnancy
  • Z3A.49 Greater than 42 weeks gestation of pregnancy
Z40 Encounter for prophylactic surgery2 codes
  • Z40.89 Encounter for other prophylactic surgery
  • Z40.9 Encounter for prophylactic surgery, unspecified
Z41 Encounter for procedures for purposes other than remedying health state2 codes
  • Z41.3 Encounter for ear piercing
  • Z41.9 Encounter for procedure for purposes other than remedying health state, unspecified
Z43 Encounter for attention to artificial openings1 code
  • Z43.9 Encounter for attention to unspecified artificial opening
Z44 Encounter for fitting and adjustment of external prosthetic device1 code
  • Z44.9 Encounter for fitting and adjustment of unspecified external prosthetic device
Z45 Encounter for adjustment and management of implanted device3 codes
  • Z45.82 Encounter for adjustment or removal of myringotomy device (stent) (tube)
  • Z45.89 Encounter for adjustment and management of other implanted devices
  • Z45.9 Encounter for adjustment and management of unspecified implanted device
Z46 Encounter for fitting and adjustment of other devices9 codes
  • Z46.0 Encounter for fitting and adjustment of spectacles and contact lenses
  • Z46.1 Encounter for fitting and adjustment of hearing aid
  • Z46.4 Encounter for fitting and adjustment of orthodontic device
  • Z46.51 Encounter for fitting and adjustment of gastric lap band
  • Z46.59 Encounter for fitting and adjustment of other gastrointestinal appliance and device
  • Z46.6 Encounter for fitting and adjustment of urinary device
  • Z46.81 Encounter for fitting and adjustment of insulin pump
  • Z46.89 Encounter for fitting and adjustment of other specified devices
  • Z46.9 Encounter for fitting and adjustment of unspecified device
Z48 Encounter for other postprocedural aftercare3 codes
  • Z48.00 Encounter for change or removal of nonsurgical wound dressing
  • Z48.01 Encounter for change or removal of surgical wound dressing
  • Z48.02 Encounter for removal of sutures
Z49 Encounter for care involving renal dialysis4 codes
  • Z49.01 Encounter for fitting and adjustment of extracorporeal dialysis catheter
  • Z49.02 Encounter for fitting and adjustment of peritoneal dialysis catheter
  • Z49.31 Encounter for adequacy testing for hemodialysis
  • Z49.32 Encounter for adequacy testing for peritoneal dialysis
Z51 Encounter for other aftercare and medical care2 codes
  • Z51.6 Encounter for desensitization to allergens
  • Z51.89 Encounter for other specified aftercare
Z52 Donors of organs and tissues11 codes
  • Z52.000 Unspecified donor, whole blood
  • Z52.008 Unspecified donor, other blood
  • Z52.010 Autologous donor, whole blood
  • Z52.018 Autologous donor, other blood
  • Z52.090 Other blood donor, whole blood
  • Z52.098 Other blood donor, other blood
  • Z52.810 Egg (Oocyte) donor under age 35, anonymous recipient
  • Z52.811 Egg (Oocyte) donor under age 35, designated recipient
  • Z52.812 Egg (Oocyte) donor age 35 and over, anonymous recipient
  • Z52.813 Egg (Oocyte) donor age 35 and over, designated recipient
  • Z52.819 Egg (Oocyte) donor, unspecified
Z53 Persons encountering health services for specific procedures and treatment, not carried out12 codes
  • Z53.01 Procedure and treatment not carried out due to patient smoking
  • Z53.09 Procedure and treatment not carried out because of other contraindication
  • Z53.1 Procedure and treatment not carried out because of patient's decision for reasons of belief and group pressure
  • Z53.20 Procedure and treatment not carried out because of patient's decision for unspecified reasons
  • Z53.21 Procedure and treatment not carried out due to patient leaving prior to being seen by health care provider
  • Z53.29 Procedure and treatment not carried out because of patient's decision for other reasons
  • Z53.31 Laparoscopic surgical procedure converted to open procedure
  • Z53.32 Thoracoscopic surgical procedure converted to open procedure
  • Z53.33 Arthroscopic surgical procedure converted to open procedure
  • Z53.39 Other specified procedure converted to open procedure
  • Z53.8 Procedure and treatment not carried out for other reasons
  • Z53.9 Procedure and treatment not carried out, unspecified reason
Z55 Problems related to education and literacy9 codes
  • Z55.0 Illiteracy and low-level literacy
  • Z55.1 Schooling unavailable and unattainable
  • Z55.2 Failed school examinations
  • Z55.3 Underachievement in school
  • Z55.4 Educational maladjustment and discord with teachers and classmates
  • Z55.5 Less than a high school diploma
  • Z55.6 Problems related to health literacy
  • Z55.8 Other problems related to education and literacy
  • Z55.9 Problems related to education and literacy, unspecified
Z56 Problems related to employment and unemployment11 codes
  • Z56.0 Unemployment, unspecified
  • Z56.1 Change of job
  • Z56.2 Threat of job loss
  • Z56.3 Stressful work schedule
  • Z56.4 Discord with boss and workmates
  • Z56.5 Uncongenial work environment
  • Z56.6 Other physical and mental strain related to work
  • Z56.81 Sexual harassment on the job
  • Z56.82 Military deployment status
  • Z56.89 Other problems related to employment
  • Z56.9 Unspecified problems related to employment
Z57 Occupational exposure to risk factors11 codes
  • Z57.0 Occupational exposure to noise
  • Z57.1 Occupational exposure to radiation
  • Z57.2 Occupational exposure to dust
  • Z57.31 Occupational exposure to environmental tobacco smoke
  • Z57.39 Occupational exposure to other air contaminants
  • Z57.4 Occupational exposure to toxic agents in agriculture
  • Z57.5 Occupational exposure to toxic agents in other industries
  • Z57.6 Occupational exposure to extreme temperature
  • Z57.7 Occupational exposure to vibration
  • Z57.8 Occupational exposure to other risk factors
  • Z57.9 Occupational exposure to unspecified risk factor
Z58 Problems related to physical environment3 codes
  • Z58.6 Inadequate drinking-water supply
  • Z58.81 Basic services unavailable in physical environment
  • Z58.89 Other problems related to physical environment
Z59 Problems related to housing and economic circumstances25 codes
  • Z59.00 Homelessness unspecified
  • Z59.01 Sheltered homelessness
  • Z59.02 Unsheltered homelessness
  • Z59.10 Inadequate housing, unspecified
  • Z59.11 Inadequate housing environmental temperature
  • Z59.12 Inadequate housing utilities
  • Z59.19 Other inadequate housing
  • Z59.2 Discord with neighbors, lodgers and landlord
  • Z59.3 Problems related to living in residential institution
  • Z59.41 Food insecurity
  • Z59.48 Other specified lack of adequate food
  • Z59.5 Extreme poverty
  • Z59.6 Low income
  • Z59.71 Insufficient health insurance coverage
  • Z59.72 Insufficient welfare support
  • Z59.811 Housing instability, housed, with risk of homelessness
  • Z59.812 Housing instability, housed, homelessness in past 12 months
  • Z59.819 Housing instability, housed unspecified
  • Z59.82 Transportation insecurity
  • Z59.861 Financial insecurity, difficulty paying for utilities
  • Z59.868 Other specified financial insecurity
  • Z59.869 Financial insecurity, unspecified
  • Z59.87 Material hardship due to limited financial resources, not elsewhere classified
  • Z59.89 Other problems related to housing and economic circumstances
  • Z59.9 Problem related to housing and economic circumstances, unspecified
Z60 Problems related to social environment7 codes
  • Z60.0 Problems of adjustment to life-cycle transitions
  • Z60.2 Problems related to living alone
  • Z60.3 Acculturation difficulty
  • Z60.4 Social exclusion and rejection
  • Z60.5 Target of (perceived) adverse discrimination and persecution
  • Z60.8 Other problems related to social environment
  • Z60.9 Problem related to social environment, unspecified
Z62 Problems related to upbringing28 codes
  • Z62.0 Inadequate parental supervision and control
  • Z62.1 Parental overprotection
  • Z62.21 Child in welfare custody
  • Z62.22 Institutional upbringing
  • Z62.23 Child in custody of non-parental relative
  • Z62.24 Child in custody of non-relative guardian
  • Z62.29 Other upbringing away from parents
  • Z62.3 Hostility towards and scapegoating of child
  • Z62.6 Inappropriate (excessive) parental pressure
  • Z62.810 Personal history of physical and sexual abuse in childhood
  • Z62.811 Personal history of psychological abuse in childhood
  • Z62.812 Personal history of neglect in childhood
  • Z62.813 Personal history of forced labor or sexual exploitation in childhood
  • Z62.814 Personal history of child financial abuse
  • Z62.815 Personal history of intimate partner abuse in childhood
  • Z62.819 Personal history of unspecified abuse in childhood
  • Z62.820 Parent-biological child conflict
  • Z62.821 Parent-adopted child conflict
  • Z62.822 Parent-foster child conflict
  • Z62.823 Parent-step child conflict
  • Z62.831 Non-parental relative-child conflict
  • Z62.832 Non-relative guardian-child conflict
  • Z62.833 Group home staff-child conflict
  • Z62.890 Parent-child estrangement NEC
  • Z62.891 Sibling rivalry
  • Z62.892 Runaway [from current living environment]
  • Z62.898 Other specified problems related to upbringing
  • Z62.9 Problem related to upbringing, unspecified
Z63 Other problems related to primary support group, including family circumstances12 codes
  • Z63.0 Problems in relationship with spouse or partner
  • Z63.1 Problems in relationship with in-laws
  • Z63.31 Absence of family member due to military deployment
  • Z63.32 Other absence of family member
  • Z63.4 Disappearance and death of family member
  • Z63.5 Disruption of family by separation and divorce
  • Z63.6 Dependent relative needing care at home
  • Z63.71 Stress on family due to return of family member from military deployment
  • Z63.72 Alcoholism and drug addiction in family
  • Z63.79 Other stressful life events affecting family and household
  • Z63.8 Other specified problems related to primary support group
  • Z63.9 Problem related to primary support group, unspecified
Z64 Problems related to certain psychosocial circumstances3 codes
  • Z64.0 Problems related to unwanted pregnancy
  • Z64.1 Problems related to multiparity
  • Z64.4 Discord with counselors
Z65 Problems related to other psychosocial circumstances8 codes
  • Z65.0 Conviction in civil and criminal proceedings without imprisonment
  • Z65.1 Imprisonment and other incarceration
  • Z65.2 Problems related to release from prison
  • Z65.3 Problems related to other legal circumstances
  • Z65.4 Victim of crime and terrorism
  • Z65.5 Exposure to disaster, war and other hostilities
  • Z65.8 Other specified problems related to psychosocial circumstances
  • Z65.9 Problem related to unspecified psychosocial circumstances
Z66 Do not resuscitate1 code
  • Z66 Do not resuscitate
Z67 Blood type14 codes
  • Z67.10 Type A blood, Rh positive
  • Z67.11 Type A blood, Rh negative
  • Z67.20 Type B blood, Rh positive
  • Z67.21 Type B blood, Rh negative
  • Z67.30 Type AB blood, Rh positive
  • Z67.31 Type AB blood, Rh negative
  • Z67.40 Type O blood, Rh positive
  • Z67.41 Type O blood, Rh negative
  • Z67.90 Unspecified blood type, Rh positive
  • Z67.91 Unspecified blood type, Rh negative
  • Z67.A1 Duffy null
  • Z67.A2 Duffy a positive
  • Z67.A3 Duffy b positive
  • Z67.A4 Duffy a and b positive
Z68 Body mass index [BMI]32 codes
  • Z68.1 Body mass index [BMI] 19.9 or less, adult
  • Z68.20 Body mass index [BMI] 20.0-20.9, adult
  • Z68.21 Body mass index [BMI] 21.0-21.9, adult
  • Z68.22 Body mass index [BMI] 22.0-22.9, adult
  • Z68.23 Body mass index [BMI] 23.0-23.9, adult
  • Z68.24 Body mass index [BMI] 24.0-24.9, adult
  • Z68.25 Body mass index [BMI] 25.0-25.9, adult
  • Z68.26 Body mass index [BMI] 26.0-26.9, adult
  • Z68.27 Body mass index [BMI] 27.0-27.9, adult
  • Z68.28 Body mass index [BMI] 28.0-28.9, adult
  • Z68.29 Body mass index [BMI] 29.0-29.9, adult
  • Z68.30 Body mass index [BMI] 30.0-30.9, adult
  • Z68.31 Body mass index [BMI] 31.0-31.9, adult
  • Z68.32 Body mass index [BMI] 32.0-32.9, adult
  • Z68.33 Body mass index [BMI] 33.0-33.9, adult
  • Z68.34 Body mass index [BMI] 34.0-34.9, adult
  • Z68.35 Body mass index [BMI] 35.0-35.9, adult
  • Z68.36 Body mass index [BMI] 36.0-36.9, adult
  • Z68.37 Body mass index [BMI] 37.0-37.9, adult
  • Z68.38 Body mass index [BMI] 38.0-38.9, adult
  • Z68.39 Body mass index [BMI] 39.0-39.9, adult
  • Z68.41 Body mass index [BMI] 40.0-44.9, adult
  • Z68.42 Body mass index [BMI] 45.0-49.9, adult
  • Z68.43 Body mass index [BMI] 50.0-59.9, adult
  • Z68.44 Body mass index [BMI] 60.0-69.9, adult
  • Z68.45 Body mass index [BMI] 70 or greater, adult
  • Z68.51 Body mass index [BMI] pediatric, less than 5th percentile for age
  • Z68.52 Body mass index [BMI] pediatric, 5th percentile to less than 85th percentile for age
  • Z68.53 Body mass index [BMI] pediatric, 85th percentile to less than 95th percentile for age
  • Z68.54 Body mass index [BMI] pediatric, 95th percentile for age to less than 120% of the 95th percentile for age
  • Z68.55 Body mass index [BMI] pediatric, 120% of the 95th percentile for age to less than 140% of the 95th percentile for age
  • Z68.56 Body mass index [BMI] pediatric, greater than or equal to 140% of the 95th percentile for age
Z69 Encounter for mental health services for victim and perpetrator of abuse6 codes
  • Z69.011 Encounter for mental health services for perpetrator of parental child abuse
  • Z69.021 Encounter for mental health services for perpetrator of non-parental child abuse
  • Z69.11 Encounter for mental health services for victim of spousal or partner abuse
  • Z69.12 Encounter for mental health services for perpetrator of spousal or partner abuse
  • Z69.81 Encounter for mental health services for victim of other abuse
  • Z69.82 Encounter for mental health services for perpetrator of other abuse
Z70 Counseling related to sexual attitude, behavior and orientation6 codes
  • Z70.0 Counseling related to sexual attitude
  • Z70.1 Counseling related to patient's sexual behavior and orientation
  • Z70.2 Counseling related to sexual behavior and orientation of third party
  • Z70.3 Counseling related to combined concerns regarding sexual attitude, behavior and orientation
  • Z70.8 Other sex counseling
  • Z70.9 Sex counseling, unspecified
Z71 Persons encountering health services for other counseling and medical advice, not elsewhere classified18 codes
  • Z71.0 Person encountering health services to consult on behalf of another person
  • Z71.1 Person with feared health complaint in whom no diagnosis is made
  • Z71.2 Person consulting for explanation of examination or test findings
  • Z71.3 Dietary counseling and surveillance
  • Z71.41 Alcohol abuse counseling and surveillance of alcoholic
  • Z71.42 Counseling for family member of alcoholic
  • Z71.51 Drug abuse counseling and surveillance of drug abuser
  • Z71.52 Counseling for family member of drug abuser
  • Z71.6 Tobacco abuse counseling
  • Z71.7 Human immunodeficiency virus [HIV] counseling
  • Z71.81 Spiritual or religious counseling
  • Z71.82 Exercise counseling
  • Z71.84 Encounter for health counseling related to travel
  • Z71.85 Encounter for immunization safety counseling
  • Z71.87 Encounter for pediatric-to-adult transition counseling
  • Z71.88 Encounter for counseling for socioeconomic factors
  • Z71.89 Other specified counseling
  • Z71.9 Counseling, unspecified
Z72 Problems related to lifestyle11 codes
  • Z72.0 Tobacco use
  • Z72.3 Lack of physical exercise
  • Z72.4 Inappropriate diet and eating habits
  • Z72.51 High risk heterosexual behavior
  • Z72.52 High risk homosexual behavior
  • Z72.53 High risk bisexual behavior
  • Z72.6 Gambling and betting
  • Z72.821 Inadequate sleep hygiene
  • Z72.823 Risk of suffocation (smothering) under another while sleeping
  • Z72.89 Other problems related to lifestyle
  • Z72.9 Problem related to lifestyle, unspecified
Z73 Problems related to life management difficulty14 codes
  • Z73.0 Burn-out
  • Z73.1 Type A behavior pattern
  • Z73.2 Lack of relaxation and leisure
  • Z73.3 Stress, not elsewhere classified
  • Z73.4 Inadequate social skills, not elsewhere classified
  • Z73.5 Social role conflict, not elsewhere classified
  • Z73.6 Limitation of activities due to disability
  • Z73.810 Behavioral insomnia of childhood, sleep-onset association type
  • Z73.811 Behavioral insomnia of childhood, limit setting type
  • Z73.812 Behavioral insomnia of childhood, combined type
  • Z73.819 Behavioral insomnia of childhood, unspecified type
  • Z73.82 Dual sensory impairment
  • Z73.89 Other problems related to life management difficulty
  • Z73.9 Problem related to life management difficulty, unspecified
Z74 Problems related to care provider dependency7 codes
  • Z74.01 Bed confinement status
  • Z74.09 Other reduced mobility
  • Z74.1 Need for assistance with personal care
  • Z74.2 Need for assistance at home and no other household member able to render care
  • Z74.3 Need for continuous supervision
  • Z74.8 Other problems related to care provider dependency
  • Z74.9 Problem related to care provider dependency, unspecified
Z75 Problems related to medical facilities and other health care8 codes
  • Z75.0 Medical services not available in home
  • Z75.1 Person awaiting admission to adequate facility elsewhere
  • Z75.2 Other waiting period for investigation and treatment
  • Z75.3 Unavailability and inaccessibility of health-care facilities
  • Z75.4 Unavailability and inaccessibility of other helping agencies
  • Z75.5 Holiday relief care
  • Z75.8 Other problems related to medical facilities and other health care
  • Z75.9 Unspecified problem related to medical facilities and other health care
Z76 Persons encountering health services in other circumstances5 codes
  • Z76.0 Encounter for issue of repeat prescription
  • Z76.2 Encounter for health supervision and care of other healthy infant and child
  • Z76.81 Expectant parent(s) prebirth pediatrician visit
  • Z76.82 Awaiting organ transplant status
  • Z76.89 Persons encountering health services in other specified circumstances
Z77 Other contact with and (suspected) exposures hazardous to health24 codes
  • Z77.010 Contact with and (suspected) exposure to arsenic
  • Z77.011 Contact with and (suspected) exposure to lead
  • Z77.012 Contact with and (suspected) exposure to uranium
  • Z77.018 Contact with and (suspected) exposure to other hazardous metals
  • Z77.020 Contact with and (suspected) exposure to aromatic amines
  • Z77.021 Contact with and (suspected) exposure to benzene
  • Z77.028 Contact with and (suspected) exposure to other hazardous aromatic compounds
  • Z77.090 Contact with and (suspected) exposure to asbestos
  • Z77.098 Contact with and (suspected) exposure to other hazardous, chiefly nonmedicinal, chemicals
  • Z77.110 Contact with and (suspected) exposure to air pollution
  • Z77.111 Contact with and (suspected) exposure to water pollution
  • Z77.112 Contact with and (suspected) exposure to soil pollution
  • Z77.118 Contact with and (suspected) exposure to other environmental pollution
  • Z77.120 Contact with and (suspected) exposure to mold (toxic)
  • Z77.121 Contact with and (suspected) exposure to harmful algae and algae toxins
  • Z77.122 Contact with and (suspected) exposure to noise
  • Z77.123 Contact with and (suspected) exposure to radon and other naturally occurring radiation
  • Z77.128 Contact with and (suspected) exposure to other hazards in the physical environment
  • Z77.21 Contact with and (suspected) exposure to potentially hazardous body fluids
  • Z77.22 Contact with and (suspected) exposure to environmental tobacco smoke (acute) (chronic)
  • Z77.29 Contact with and (suspected) exposure to other hazardous substances
  • Z77.31 Contact with and (suspected) exposure to Gulf War theater
  • Z77.39 Contact with and (suspected) exposure to other war theater
  • Z77.9 Other contact with and (suspected) exposures hazardous to health
Z78 Other specified health status3 codes
  • Z78.0 Asymptomatic menopausal state
  • Z78.1 Physical restraint status
  • Z78.9 Other specified health status
Z79 Long term (current) drug therapy26 codes
  • Z79.02 Long term (current) use of antithrombotics/antiplatelets
  • Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID)
  • Z79.2 Long term (current) use of antibiotics
  • Z79.51 Long term (current) use of inhaled steroids
  • Z79.52 Long term (current) use of systemic steroids
  • Z79.60 Long term (current) use of unspecified immunomodulators and immunosuppressants
  • Z79.61 Long term (current) use of immunomodulator
  • Z79.620 Long term (current) use of immunosuppressive biologic
  • Z79.621 Long term (current) use of calcineurin inhibitor
  • Z79.622 Long term (current) use of Janus kinase inhibitor
  • Z79.623 Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
  • Z79.624 Long term (current) use of inhibitors of nucleotide synthesis
  • Z79.630 Long term (current) use of alkylating agent
  • Z79.631 Long term (current) use of antimetabolite agent
  • Z79.632 Long term (current) use of antitumor antibiotic
  • Z79.633 Long term (current) use of mitotic inhibitor
  • Z79.634 Long term (current) use of topoisomerase inhibitor
  • Z79.64 Long term (current) use of myelosuppressive agent
  • Z79.69 Long term (current) use of other immunomodulators and immunosuppressants
  • Z79.810 Long term (current) use of selective estrogen receptor modulators (SERMs)
  • Z79.811 Long term (current) use of aromatase inhibitors
  • Z79.818 Long term (current) use of other agents affecting estrogen receptors and estrogen levels
  • Z79.83 Long term (current) use of bisphosphonates
  • Z79.84 Long term (current) use of oral hypoglycemic drugs
  • Z79.85 Long-term (current) use of injectable non-insulin antidiabetic drugs
  • Z79.890 Hormone replacement therapy
Z80 Family history of primary malignant neoplasm16 codes
  • Z80.0 Family history of malignant neoplasm of digestive organs
  • Z80.1 Family history of malignant neoplasm of trachea, bronchus and lung
  • Z80.2 Family history of malignant neoplasm of other respiratory and intrathoracic organs
  • Z80.3 Family history of malignant neoplasm of breast
  • Z80.41 Family history of malignant neoplasm of ovary
  • Z80.42 Family history of malignant neoplasm of prostate
  • Z80.43 Family history of malignant neoplasm of testis
  • Z80.44 Family history of malignant neoplasm of fallopian tube(s)
  • Z80.49 Family history of malignant neoplasm of other genital organs
  • Z80.51 Family history of malignant neoplasm of kidney
  • Z80.52 Family history of malignant neoplasm of bladder
  • Z80.59 Family history of malignant neoplasm of other urinary tract organ
  • Z80.6 Family history of leukemia
  • Z80.7 Family history of other malignant neoplasms of lymphoid, hematopoietic and related tissues
  • Z80.8 Family history of malignant neoplasm of other organs or systems
  • Z80.9 Family history of malignant neoplasm, unspecified
Z81 Family history of mental and behavioral disorders6 codes
  • Z81.0 Family history of intellectual disabilities
  • Z81.1 Family history of alcohol abuse and dependence
  • Z81.2 Family history of tobacco abuse and dependence
  • Z81.3 Family history of other psychoactive substance abuse and dependence
  • Z81.4 Family history of other substance abuse and dependence
  • Z81.8 Family history of other mental and behavioral disorders
Z82 Family history of certain disabilities and chronic diseases (leading to disablement)13 codes
  • Z82.0 Family history of epilepsy and other diseases of the nervous system
  • Z82.1 Family history of blindness and visual loss
  • Z82.2 Family history of deafness and hearing loss
  • Z82.3 Family history of stroke
  • Z82.41 Family history of sudden cardiac death
  • Z82.49 Family history of ischemic heart disease and other diseases of the circulatory system
  • Z82.5 Family history of asthma and other chronic lower respiratory diseases
  • Z82.61 Family history of arthritis
  • Z82.62 Family history of osteoporosis
  • Z82.69 Family history of other diseases of the musculoskeletal system and connective tissue
  • Z82.71 Family history of polycystic kidney
  • Z82.79 Family history of other congenital malformations, deformations and chromosomal abnormalities
  • Z82.8 Family history of other disabilities and chronic diseases leading to disablement, not elsewhere classified
Z83 Family history of other specific disorders19 codes
  • Z83.0 Family history of human immunodeficiency virus [HIV] disease
  • Z83.1 Family history of other infectious and parasitic diseases
  • Z83.2 Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
  • Z83.3 Family history of diabetes mellitus
  • Z83.41 Family history of multiple endocrine neoplasia [MEN] syndrome
  • Z83.42 Family history of familial hypercholesterolemia
  • Z83.430 Family history of elevated lipoprotein(a)
  • Z83.438 Family history of other disorder of lipoprotein metabolism and other lipidemia
  • Z83.49 Family history of other endocrine, nutritional and metabolic diseases
  • Z83.511 Family history of glaucoma
  • Z83.518 Family history of other specified eye disorder
  • Z83.52 Family history of ear disorders
  • Z83.6 Family history of other diseases of the respiratory system
  • Z83.710 Family history of adenomatous and serrated polyps
  • Z83.711 Family history of hyperplastic colon polyps
  • Z83.718 Family history of other colon polyps
  • Z83.719 Family history of colon polyps, unspecified
  • Z83.72 Family history of familial adenomatous polyposis
  • Z83.79 Family history of other diseases of the digestive system
Z84 Family history of other conditions9 codes
  • Z84.0 Family history of diseases of the skin and subcutaneous tissue
  • Z84.11 Family history of APOL1-mediated kidney disease [AMKD]
  • Z84.19 Family history of other disorders of kidney and ureter
  • Z84.2 Family history of other diseases of the genitourinary system
  • Z84.3 Family history of consanguinity
  • Z84.81 Family history of carrier of genetic disease
  • Z84.82 Family history of sudden infant death syndrome
  • Z84.89 Family history of other specified conditions
  • Z84.A Family history of exposure to diethylstilbestrol
Z85 Personal history of malignant neoplasm60 codes
  • Z85.00 Personal history of malignant neoplasm of unspecified digestive organ
  • Z85.01 Personal history of malignant neoplasm of esophagus
  • Z85.020 Personal history of malignant carcinoid tumor of stomach
  • Z85.028 Personal history of other malignant neoplasm of stomach
  • Z85.030 Personal history of malignant carcinoid tumor of large intestine
  • Z85.038 Personal history of other malignant neoplasm of large intestine
  • Z85.040 Personal history of malignant carcinoid tumor of rectum
  • Z85.048 Personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus
  • Z85.05 Personal history of malignant neoplasm of liver
  • Z85.060 Personal history of malignant carcinoid tumor of small intestine
  • Z85.068 Personal history of other malignant neoplasm of small intestine
  • Z85.07 Personal history of malignant neoplasm of pancreas
  • Z85.09 Personal history of malignant neoplasm of other digestive organs
  • Z85.110 Personal history of malignant carcinoid tumor of bronchus and lung
  • Z85.118 Personal history of other malignant neoplasm of bronchus and lung
  • Z85.12 Personal history of malignant neoplasm of trachea
  • Z85.20 Personal history of malignant neoplasm of unspecified respiratory organ
  • Z85.21 Personal history of malignant neoplasm of larynx
  • Z85.22 Personal history of malignant neoplasm of nasal cavities, middle ear, and accessory sinuses
  • Z85.230 Personal history of malignant carcinoid tumor of thymus
  • Z85.238 Personal history of other malignant neoplasm of thymus
  • Z85.29 Personal history of malignant neoplasm of other respiratory and intrathoracic organs
  • Z85.3 Personal history of malignant neoplasm of breast
  • Z85.40 Personal history of malignant neoplasm of unspecified female genital organ
  • Z85.41 Personal history of malignant neoplasm of cervix uteri
  • Z85.42 Personal history of malignant neoplasm of other parts of uterus
  • Z85.43 Personal history of malignant neoplasm of ovary
  • Z85.44 Personal history of malignant neoplasm of other female genital organs
  • Z85.45 Personal history of malignant neoplasm of unspecified male genital organ
  • Z85.46 Personal history of malignant neoplasm of prostate
  • Z85.47 Personal history of malignant neoplasm of testis
  • Z85.48 Personal history of malignant neoplasm of epididymis
  • Z85.49 Personal history of malignant neoplasm of other male genital organs
  • Z85.4A Personal history of malignant neoplasm of fallopian tube(s)
  • Z85.50 Personal history of malignant neoplasm of unspecified urinary tract organ
  • Z85.51 Personal history of malignant neoplasm of bladder
  • Z85.520 Personal history of malignant carcinoid tumor of kidney
  • Z85.528 Personal history of other malignant neoplasm of kidney
  • Z85.53 Personal history of malignant neoplasm of renal pelvis
  • Z85.54 Personal history of malignant neoplasm of ureter
  • Z85.59 Personal history of malignant neoplasm of other urinary tract organ
  • Z85.6 Personal history of leukemia
  • Z85.71 Personal history of Hodgkin lymphoma
  • Z85.72 Personal history of non-Hodgkin lymphomas
  • Z85.79 Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues
  • Z85.810 Personal history of malignant neoplasm of tongue
  • Z85.818 Personal history of malignant neoplasm of other sites of lip, oral cavity, and pharynx
  • Z85.819 Personal history of malignant neoplasm of unspecified site of lip, oral cavity, and pharynx
  • Z85.820 Personal history of malignant melanoma of skin
  • Z85.821 Personal history of Merkel cell carcinoma
  • Z85.828 Personal history of other malignant neoplasm of skin
  • Z85.830 Personal history of malignant neoplasm of bone
  • Z85.831 Personal history of malignant neoplasm of soft tissue
  • Z85.840 Personal history of malignant neoplasm of eye
  • Z85.841 Personal history of malignant neoplasm of brain
  • Z85.848 Personal history of malignant neoplasm of other parts of nervous tissue
  • Z85.850 Personal history of malignant neoplasm of thyroid
  • Z85.858 Personal history of malignant neoplasm of other endocrine glands
  • Z85.89 Personal history of malignant neoplasm of other organs and systems
  • Z85.9 Personal history of malignant neoplasm, unspecified
Z86 Personal history of certain other diseases39 codes
  • Z86.000 Personal history of in-situ neoplasm of breast
  • Z86.001 Personal history of in-situ neoplasm of cervix uteri
  • Z86.002 Personal history of in-situ neoplasm of other and unspecified genital organs
  • Z86.003 Personal history of in-situ neoplasm of oral cavity, esophagus and stomach
  • Z86.004 Personal history of in-situ neoplasm of other and unspecified digestive organs
  • Z86.005 Personal history of in-situ neoplasm of middle ear and respiratory system
  • Z86.006 Personal history of melanoma in-situ
  • Z86.007 Personal history of in-situ neoplasm of skin
  • Z86.008 Personal history of in-situ neoplasm of other site
  • Z86.00A Personal history of in-situ neoplasm of the fallopian tube(s)
  • Z86.0100 Personal history of colon polyps, unspecified
  • Z86.0101 Personal history of adenomatous and serrated colon polyps
  • Z86.0102 Personal history of hyperplastic colon polyps
  • Z86.0109 Personal history of other colon polyps
  • Z86.011 Personal history of benign neoplasm of the brain
  • Z86.012 Personal history of benign carcinoid tumor
  • Z86.018 Personal history of other benign neoplasm
  • Z86.03 Personal history of neoplasm of uncertain behavior
  • Z86.11 Personal history of tuberculosis
  • Z86.12 Personal history of poliomyelitis
  • Z86.13 Personal history of malaria
  • Z86.14 Personal history of Methicillin resistant Staphylococcus aureus infection
  • Z86.15 Personal history of latent tuberculosis infection
  • Z86.16 Personal history of COVID-19
  • Z86.19 Personal history of other infectious and parasitic diseases
  • Z86.2 Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
  • Z86.31 Personal history of diabetic foot ulcer
  • Z86.32 Personal history of gestational diabetes
  • Z86.39 Personal history of other endocrine, nutritional and metabolic disease
  • Z86.51 Personal history of combat and operational stress reaction
  • Z86.59 Personal history of other mental and behavioral disorders
  • Z86.61 Personal history of infections of the central nervous system
  • Z86.69 Personal history of other diseases of the nervous system and sense organs
  • Z86.711 Personal history of pulmonary embolism
  • Z86.718 Personal history of other venous thrombosis and embolism
  • Z86.72 Personal history of thrombophlebitis
  • Z86.73 Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits
  • Z86.74 Personal history of sudden cardiac arrest
  • Z86.79 Personal history of other diseases of the circulatory system
Z87 Personal history of other diseases and conditions48 codes
  • Z87.01 Personal history of pneumonia (recurrent)
  • Z87.09 Personal history of other diseases of the respiratory system
  • Z87.11 Personal history of peptic ulcer disease
  • Z87.19 Personal history of other diseases of the digestive system
  • Z87.2 Personal history of diseases of the skin and subcutaneous tissue
  • Z87.310 Personal history of (healed) osteoporosis fracture
  • Z87.311 Personal history of (healed) other pathological fracture
  • Z87.312 Personal history of (healed) stress fracture
  • Z87.39 Personal history of other diseases of the musculoskeletal system and connective tissue
  • Z87.410 Personal history of cervical dysplasia
  • Z87.411 Personal history of vaginal dysplasia
  • Z87.412 Personal history of vulvar dysplasia
  • Z87.42 Personal history of other diseases of the female genital tract
  • Z87.430 Personal history of prostatic dysplasia
  • Z87.438 Personal history of other diseases of male genital organs
  • Z87.440 Personal history of urinary (tract) infections
  • Z87.441 Personal history of nephrotic syndrome
  • Z87.442 Personal history of urinary calculi
  • Z87.448 Personal history of other diseases of urinary system
  • Z87.51 Personal history of pre-term labor
  • Z87.59 Personal history of other complications of pregnancy, childbirth and the puerperium
  • Z87.61 Personal history of (corrected) necrotizing enterocolitis of newborn
  • Z87.68 Personal history of other (corrected) conditions arising in the perinatal period
  • Z87.710 Personal history of (corrected) hypospadias
  • Z87.718 Personal history of other specified (corrected) congenital malformations of genitourinary system
  • Z87.720 Personal history of (corrected) congenital malformations of eye
  • Z87.721 Personal history of (corrected) congenital malformations of ear
  • Z87.728 Personal history of other specified (corrected) congenital malformations of nervous system and sense organs
  • Z87.730 Personal history of (corrected) cleft lip and palate
  • Z87.731 Personal history of (corrected) tracheoesophageal fistula or atresia
  • Z87.732 Personal history of (corrected) persistent cloaca or cloacal malformations
  • Z87.738 Personal history of other specified (corrected) congenital malformations of digestive system
  • Z87.74 Personal history of (corrected) congenital malformations of heart and circulatory system
  • Z87.75 Personal history of (corrected) congenital malformations of respiratory system
  • Z87.760 Personal history of (corrected) congenital diaphragmatic hernia or other congenital diaphragm malformations
  • Z87.761 Personal history of (corrected) gastroschisis
  • Z87.762 Personal history of (corrected) prune belly malformation
  • Z87.763 Personal history of other (corrected) congenital abdominal wall malformations
  • Z87.768 Personal history of other specified (corrected) congenital malformations of integument, limbs and musculoskeletal system
  • Z87.790 Personal history of (corrected) congenital malformations of face and neck
  • Z87.798 Personal history of other (corrected) congenital malformations
  • Z87.81 Personal history of (healed) traumatic fracture
  • Z87.820 Personal history of traumatic brain injury
  • Z87.821 Personal history of retained foreign body fully removed
  • Z87.828 Personal history of other (healed) physical injury and trauma
  • Z87.891 Personal history of nicotine dependence
  • Z87.892 Personal history of anaphylaxis
  • Z87.898 Personal history of other specified conditions
Z88 Allergy status to drugs, medicaments and biological substances10 codes
  • Z88.0 Allergy status to penicillin
  • Z88.1 Allergy status to other antibiotic agents
  • Z88.2 Allergy status to sulfonamides
  • Z88.3 Allergy status to other anti-infective agents
  • Z88.4 Allergy status to anesthetic agent
  • Z88.5 Allergy status to narcotic agent
  • Z88.6 Allergy status to analgesic agent
  • Z88.7 Allergy status to serum and vaccine
  • Z88.8 Allergy status to other drugs, medicaments and biological substances
  • Z88.9 Allergy status to unspecified drugs, medicaments and biological substances
Z89 Acquired absence of limb49 codes
  • Z89.011 Acquired absence of right thumb
  • Z89.012 Acquired absence of left thumb
  • Z89.019 Acquired absence of unspecified thumb
  • Z89.021 Acquired absence of right finger(s)
  • Z89.022 Acquired absence of left finger(s)
  • Z89.029 Acquired absence of unspecified finger(s)
  • Z89.111 Acquired absence of right hand
  • Z89.112 Acquired absence of left hand
  • Z89.119 Acquired absence of unspecified hand
  • Z89.121 Acquired absence of right wrist
  • Z89.122 Acquired absence of left wrist
  • Z89.129 Acquired absence of unspecified wrist
  • Z89.201 Acquired absence of right upper limb, unspecified level
  • Z89.202 Acquired absence of left upper limb, unspecified level
  • Z89.209 Acquired absence of unspecified upper limb, unspecified level
  • Z89.211 Acquired absence of right upper limb below elbow
  • Z89.212 Acquired absence of left upper limb below elbow
  • Z89.219 Acquired absence of unspecified upper limb below elbow
  • Z89.221 Acquired absence of right upper limb above elbow
  • Z89.222 Acquired absence of left upper limb above elbow
  • Z89.229 Acquired absence of unspecified upper limb above elbow
  • Z89.231 Acquired absence of right shoulder
  • Z89.232 Acquired absence of left shoulder
  • Z89.239 Acquired absence of unspecified shoulder
  • Z89.411 Acquired absence of right great toe
  • Z89.412 Acquired absence of left great toe
  • Z89.419 Acquired absence of unspecified great toe
  • Z89.421 Acquired absence of other right toe(s)
  • Z89.422 Acquired absence of other left toe(s)
  • Z89.429 Acquired absence of other toe(s), unspecified side
  • Z89.431 Acquired absence of right foot
  • Z89.432 Acquired absence of left foot
  • Z89.439 Acquired absence of unspecified foot
  • Z89.441 Acquired absence of right ankle
  • Z89.442 Acquired absence of left ankle
  • Z89.449 Acquired absence of unspecified ankle
  • Z89.511 Acquired absence of right leg below knee
  • Z89.512 Acquired absence of left leg below knee
  • Z89.519 Acquired absence of unspecified leg below knee
  • Z89.521 Acquired absence of right knee
  • Z89.522 Acquired absence of left knee
  • Z89.529 Acquired absence of unspecified knee
  • Z89.611 Acquired absence of right leg above knee
  • Z89.612 Acquired absence of left leg above knee
  • Z89.619 Acquired absence of unspecified leg above knee
  • Z89.621 Acquired absence of right hip joint
  • Z89.622 Acquired absence of left hip joint
  • Z89.629 Acquired absence of unspecified hip joint
  • Z89.9 Acquired absence of limb, unspecified
Z90 Acquired absence of organs, not elsewhere classified18 codes
  • Z90.01 Acquired absence of eye
  • Z90.02 Acquired absence of larynx
  • Z90.09 Acquired absence of other part of head and neck
  • Z90.2 Acquired absence of lung [part of]
  • Z90.3 Acquired absence of stomach [part of]
  • Z90.410 Acquired total absence of pancreas
  • Z90.411 Acquired partial absence of pancreas
  • Z90.49 Acquired absence of other specified parts of digestive tract
  • Z90.5 Acquired absence of kidney
  • Z90.6 Acquired absence of other parts of urinary tract
  • Z90.710 Acquired absence of both cervix and uterus
  • Z90.711 Acquired absence of uterus with remaining cervical stump
  • Z90.712 Acquired absence of cervix with remaining uterus
  • Z90.721 Acquired absence of ovaries, unilateral
  • Z90.722 Acquired absence of ovaries, bilateral
  • Z90.79 Acquired absence of other genital organ(s)
  • Z90.81 Acquired absence of spleen
  • Z90.89 Acquired absence of other organs
Z91 Personal risk factors, not elsewhere classified61 codes
  • Z91.010 Allergy to peanuts
  • Z91.0110 Allergy to milk products, unspecified
  • Z91.0111 Allergy to milk products with tolerance to baked milk
  • Z91.0112 Allergy to milk products with reactivity to baked milk
  • Z91.0120 Allergy to eggs, unspecified
  • Z91.0121 Allergy to eggs with tolerance to baked egg
  • Z91.0122 Allergy to eggs with reactivity to baked egg
  • Z91.013 Allergy to seafood
  • Z91.014 Allergy to mammalian meats
  • Z91.018 Allergy to other foods
  • Z91.02 Food additives allergy status
  • Z91.030 Bee allergy status
  • Z91.038 Other insect allergy status
  • Z91.040 Latex allergy status
  • Z91.041 Radiographic dye allergy status
  • Z91.048 Other nonmedicinal substance allergy status
  • Z91.09 Other allergy status, other than to drugs and biological substances
  • Z91.110 Patient's noncompliance with dietary regimen due to financial hardship
  • Z91.118 Patient's noncompliance with dietary regimen for other reason
  • Z91.119 Patient's noncompliance with dietary regimen due to unspecified reason
  • Z91.120 Patient's intentional underdosing of medication regimen due to financial hardship
  • Z91.128 Patient's intentional underdosing of medication regimen for other reason
  • Z91.130 Patient's unintentional underdosing of medication regimen due to age-related debility
  • Z91.138 Patient's unintentional underdosing of medication regimen for other reason
  • Z91.141 Patient's other noncompliance with medication regimen due to financial hardship
  • Z91.148 Patient's other noncompliance with medication regimen for other reason
  • Z91.151 Patient's noncompliance with renal dialysis due to financial hardship
  • Z91.158 Patient's noncompliance with renal dialysis for other reason
  • Z91.190 Patient's noncompliance with other medical treatment and regimen due to financial hardship
  • Z91.198 Patient's noncompliance with other medical treatment and regimen for other reason
  • Z91.199 Patient's noncompliance with other medical treatment and regimen due to unspecified reason
  • Z91.410 Personal history of adult physical and sexual abuse
  • Z91.411 Personal history of adult psychological abuse
  • Z91.412 Personal history of adult neglect
  • Z91.413 Personal history of adult financial abuse
  • Z91.414 Personal history of adult intimate partner abuse
  • Z91.419 Personal history of unspecified adult abuse
  • Z91.42 Personal history of forced labor or sexual exploitation
  • Z91.49 Other personal history of psychological trauma, not elsewhere classified
  • Z91.51 Personal history of suicidal behavior
  • Z91.52 Personal history of nonsuicidal self-harm
  • Z91.81 History of falling
  • Z91.82 Personal history of military deployment
  • Z91.841 Risk for dental caries, low
  • Z91.842 Risk for dental caries, moderate
  • Z91.843 Risk for dental caries, high
  • Z91.849 Unspecified risk for dental caries
  • Z91.85 Personal history of military service
  • Z91.89 Other specified personal risk factors, not elsewhere classified
  • Z91.A10 Caregiver's noncompliance with patient's dietary regimen due to financial hardship
  • Z91.A18 Caregiver's noncompliance with patient's dietary regimen for other reason
  • Z91.A20 Caregiver's intentional underdosing of patient's medication regimen due to financial hardship
  • Z91.A28 Caregiver's intentional underdosing of medication regimen for other reason
  • Z91.A3 Caregiver's unintentional underdosing of patient's medication regimen
  • Z91.A41 Caregiver's other noncompliance with patient's medication regimen due to financial hardship
  • Z91.A48 Caregiver's other noncompliance with patient's medication regimen for other reason
  • Z91.A51 Caregiver's noncompliance with patient's renal dialysis due to financial hardship
  • Z91.A58 Caregiver's noncompliance with patient's renal dialysis for other reason
  • Z91.A91 Caregiver's noncompliance with patient's other medical treatment and regimen due to financial hardship
  • Z91.A98 Caregiver's noncompliance with patient's other medical treatment and regimen for other reason
  • Z91.B Personal risk factor of exposure to diethylstilbestrol
Z92 Personal history of medical treatment19 codes
  • Z92.0 Personal history of contraception
  • Z92.21 Personal history of antineoplastic chemotherapy
  • Z92.22 Personal history of monoclonal drug therapy
  • Z92.23 Personal history of estrogen therapy
  • Z92.240 Personal history of inhaled steroid therapy
  • Z92.241 Personal history of systemic steroid therapy
  • Z92.25 Personal history of immunosuppression therapy
  • Z92.26 Personal history of immune checkpoint inhibitor therapy
  • Z92.29 Personal history of other drug therapy
  • Z92.3 Personal history of irradiation
  • Z92.81 Personal history of extracorporeal membrane oxygenation (ECMO)
  • Z92.82 Status post administration of tPA (rtPA) in a different facility within the last 24 hours prior to admission to current facility
  • Z92.83 Personal history of failed moderate sedation
  • Z92.84 Personal history of unintended awareness under general anesthesia
  • Z92.850 Personal history of Chimeric Antigen Receptor T-cell therapy
  • Z92.858 Personal history of other cellular therapy
  • Z92.859 Personal history of cellular therapy, unspecified
  • Z92.86 Personal history of gene therapy
  • Z92.89 Personal history of other medical treatment
Z93 Artificial opening status12 codes
  • Z93.0 Tracheostomy status
  • Z93.1 Gastrostomy status
  • Z93.2 Ileostomy status
  • Z93.3 Colostomy status
  • Z93.4 Other artificial openings of gastrointestinal tract status
  • Z93.50 Unspecified cystostomy status
  • Z93.51 Cutaneous-vesicostomy status
  • Z93.52 Appendico-vesicostomy status
  • Z93.59 Other cystostomy status
  • Z93.6 Other artificial openings of urinary tract status
  • Z93.8 Other artificial opening status
  • Z93.9 Artificial opening status, unspecified
Z94 Transplanted organ and tissue status14 codes
  • Z94.0 Kidney transplant status
  • Z94.1 Heart transplant status
  • Z94.2 Lung transplant status
  • Z94.3 Heart and lungs transplant status
  • Z94.4 Liver transplant status
  • Z94.5 Skin transplant status
  • Z94.6 Bone transplant status
  • Z94.7 Corneal transplant status
  • Z94.81 Bone marrow transplant status
  • Z94.82 Intestine transplant status
  • Z94.83 Pancreas transplant status
  • Z94.84 Stem cells transplant status
  • Z94.89 Other transplanted organ and tissue status
  • Z94.9 Transplanted organ and tissue status, unspecified
Z95 Presence of cardiac and vascular implants and grafts13 codes
  • Z95.0 Presence of cardiac pacemaker
  • Z95.1 Presence of aortocoronary bypass graft
  • Z95.2 Presence of prosthetic heart valve
  • Z95.3 Presence of xenogenic heart valve
  • Z95.4 Presence of other heart-valve replacement
  • Z95.5 Presence of coronary angioplasty implant and graft
  • Z95.810 Presence of automatic (implantable) cardiac defibrillator
  • Z95.811 Presence of heart assist device
  • Z95.812 Presence of fully implantable artificial heart
  • Z95.818 Presence of other cardiac implants and grafts
  • Z95.820 Peripheral vascular angioplasty status with implants and grafts
  • Z95.828 Presence of other vascular implants and grafts
  • Z95.9 Presence of cardiac and vascular implant and graft, unspecified
Z96 Presence of other functional implants40 codes
  • Z96.0 Presence of urogenital implants
  • Z96.1 Presence of intraocular lens
  • Z96.20 Presence of otological and audiological implant, unspecified
  • Z96.21 Cochlear implant status
  • Z96.22 Myringotomy tube(s) status
  • Z96.29 Presence of other otological and audiological implants
  • Z96.3 Presence of artificial larynx
  • Z96.41 Presence of insulin pump (external) (internal)
  • Z96.49 Presence of other endocrine implants
  • Z96.5 Presence of tooth-root and mandibular implants
  • Z96.60 Presence of unspecified orthopedic joint implant
  • Z96.611 Presence of right artificial shoulder joint
  • Z96.612 Presence of left artificial shoulder joint
  • Z96.619 Presence of unspecified artificial shoulder joint
  • Z96.621 Presence of right artificial elbow joint
  • Z96.622 Presence of left artificial elbow joint
  • Z96.629 Presence of unspecified artificial elbow joint
  • Z96.631 Presence of right artificial wrist joint
  • Z96.632 Presence of left artificial wrist joint
  • Z96.639 Presence of unspecified artificial wrist joint
  • Z96.641 Presence of right artificial hip joint
  • Z96.642 Presence of left artificial hip joint
  • Z96.643 Presence of artificial hip joint, bilateral
  • Z96.649 Presence of unspecified artificial hip joint
  • Z96.651 Presence of right artificial knee joint
  • Z96.652 Presence of left artificial knee joint
  • Z96.653 Presence of artificial knee joint, bilateral
  • Z96.659 Presence of unspecified artificial knee joint
  • Z96.661 Presence of right artificial ankle joint
  • Z96.662 Presence of left artificial ankle joint
  • Z96.669 Presence of unspecified artificial ankle joint
  • Z96.691 Finger-joint replacement of right hand
  • Z96.692 Finger-joint replacement of left hand
  • Z96.693 Finger-joint replacement, bilateral
  • Z96.698 Presence of other orthopedic joint implants
  • Z96.7 Presence of other bone and tendon implants
  • Z96.81 Presence of artificial skin
  • Z96.82 Presence of neurostimulator
  • Z96.89 Presence of other specified functional implants
  • Z96.9 Presence of functional implant, unspecified
Z97 Presence of other devices13 codes
  • Z97.0 Presence of artificial eye
  • Z97.10 Presence of artificial limb (complete) (partial), unspecified
  • Z97.11 Presence of artificial right arm (complete) (partial)
  • Z97.12 Presence of artificial left arm (complete) (partial)
  • Z97.13 Presence of artificial right leg (complete) (partial)
  • Z97.14 Presence of artificial left leg (complete) (partial)
  • Z97.15 Presence of artificial arms, bilateral (complete) (partial)
  • Z97.16 Presence of artificial legs, bilateral (complete) (partial)
  • Z97.2 Presence of dental prosthetic device (complete) (partial)
  • Z97.3 Presence of spectacles and contact lenses
  • Z97.4 Presence of external hearing-aid
  • Z97.5 Presence of (intrauterine) contraceptive device
  • Z97.8 Presence of other specified devices
Z98 Other postprocedural states23 codes
  • Z98.0 Intestinal bypass and anastomosis status
  • Z98.1 Arthrodesis status
  • Z98.2 Presence of cerebrospinal fluid drainage device
  • Z98.3 Post therapeutic collapse of lung status
  • Z98.41 Cataract extraction status, right eye
  • Z98.42 Cataract extraction status, left eye
  • Z98.49 Cataract extraction status, unspecified eye
  • Z98.51 Tubal ligation status
  • Z98.52 Vasectomy status
  • Z98.61 Coronary angioplasty status
  • Z98.62 Peripheral vascular angioplasty status
  • Z98.810 Dental sealant status
  • Z98.811 Dental restoration status
  • Z98.818 Other dental procedure status
  • Z98.82 Breast implant status
  • Z98.83 Filtering (vitreous) bleb after glaucoma surgery status
  • Z98.84 Bariatric surgery status
  • Z98.85 Transplanted organ removal status
  • Z98.86 Personal history of breast implant removal
  • Z98.870 Personal history of in utero procedure during pregnancy
  • Z98.871 Personal history of in utero procedure while a fetus
  • Z98.890 Other specified postprocedural states
  • Z98.891 History of uterine scar from previous surgery
Z99 Dependence on enabling machines and devices, not elsewhere classified5 codes
  • Z99.0 Dependence on aspirator
  • Z99.2 Dependence on renal dialysis
  • Z99.3 Dependence on wheelchair
  • Z99.81 Dependence on supplemental oxygen
  • Z99.89 Dependence on other enabling machines and devices

Questions About This Code Edit

What is the unacceptable principal diagnosis Medicare code edit?

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis. Claims that fail the check are flagged for correction before payment.

How many ICD-10-CM codes are on the unacceptable principal diagnosis list?

The FY 2026 list contains 2,657 diagnosis codes across 150 code categories, imported from the CMS Definitions of Medicare Code Edits v43.0.

What happens when a claim triggers this edit?

These codes describe circumstances that influence health status without representing a current illness, so the MCE rejects any inpatient claim that lists one as the principal diagnosis. Reported as secondary diagnoses they are fine.

Does this edit make the codes invalid for billing?

No. Every code on this list is a valid ICD-10-CM code. The edit checks how the code is used on the claim, not whether the code exists.

Other ICD-10-CM Medicare Code Edits

Adult DiagnosesNewborn DiagnosesPediatric DiagnosesMaternity DiagnosesManifestation DiagnosesQuestionable AdmissionOutcome of DeliveryUnspecified Codes

Source: CMS Definitions of Medicare Code Edits v43.0, effective October 1, 2025 through September 30, 2026. Code lists are imported directly from the official manual. See also the ICD-10-PCS procedure edits and the MS-DRG list.